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Chapter 1
General introduction, aims and 
structure of the thesis
Multiple sclerosis (MS), with its unknown etiology and still not understood 
occurrence, has attracted a lot of attention from researchers over the 
past two decades. This study tries to contribute to the understanding of 
perceived health status in patients with MS. This ﬁ  rst chapter describes 
the disease, the aim of this study, the theoretical model used, the research 
questions employed and the structure of this thesis.
1.1 Multiple  sclerosis
MS is considered an inﬂ   ammatory neurodegenerative disease of the 
central nervous system, with onset usually occuring in early adult life. 
It is characterized by demyelinization and primary or secondary axonal 
degeneration, with the loss of dendrites and neurons contributing to 
the irreversible functional impairment observed in affected individuals. 
It attacks more than 2 million people worldwide, the ratio of women to 
men affected being 2:1. Onset of the illness generally occurs between 20-50 
years of age (1-3). 
Although descriptions of MS symptoms date back as far as the 
Middle Ages, MS was ﬁ  rst recognized as a distinct disease only in the 
nineteenth century. The ﬁ  rst pathologic report was published in 1868 
by J.M. Charcot, a professor of Neurology at the University of Paris. He 
examined the brain of a young woman and documented the characteristic 
scars, which he describes as “la sclérose en plaques” (1). 
The prevalence of MS varies considerably around the world. It is 
highest in northern Europe, southern Australia and the middle part of 
North America. There has been a trend toward an increasing prevalence 
and incidence, particularly in southern Europe (3, 4, 5). Slovakia has 
a relatively high rate of MS prevalence, with more than 30 cases reported 
per 100 000 persons (6). The reasons for the variations in the prevalence 
and incidence of MS worldwide are not understood, as the etiology of 
MS is itself unknown. MS is assumed to be a multifactorial disorder, in 
which environmental factors are hypothesized to interact with genetically 
susceptible individuals. Pediatric MS and late-onset MS (i.e. clinical onset 
occuring later than the ﬁ  fth decade) are rare (4, 7). 8 CHAPTER  1
1.1.1 Diagnostics  criteria
The most widely used criteria for the diagnosis of MS are the Poser 
Committee criteria and a new system of classiﬁ  cation, the McDonald 
criteria. They incorporate magnetic resonance imaging (MRI) to 
demonstrate multiple areas of involvement and also involvement over 
time with the appearance of new enhancing lesions. Patients have 
been diagnosed as having MS or possibly having MS according to 
these indicatiors over the past two decades (8, 9). Advanced MRI and 
spectroscopy may allow clinicians to follow the pathological progression 
of the disease and to monitor the response to treatment (4). 
All patients in this thesis were diagnosed in accordance with the 
McDonald criteria, which allows for earlier conﬁ  rmation of a diagnosis 
of MS and an earlier decision on therapy. This diagnosis was conﬁ  rmed 
by one neurologist (8, 9). 
1.1.2  Clinical course and disability
The clinical course of MS shows heterogeneity among patients and within 
the same patient. Decisions on the categorization of the clinical course 
of MS have been made and later on reduced, thus resulting in confusing 
terminology:
-   relapsing-remitting MS  (RR-MS) – the disease as it occurs in the 
majority of MS patients (~85%) with relapses with full recovery, 
or with sequelae upon recovery and periods between relapses 
characterized by a lack of disease progression. Fifteen percent 
of patients with RR-MS experience a mild course with minimal 
disability after 15 years; this is therefore called benign MS. 
-   progressive-relapsing MS (PR-MS) – progressive disease from the 
onset on (~5%), with clear relapses, and periods between relapses 
showing continuing progression.
-   secondary-progressive MS (SP-MS) – initially categorized as the RR-MS 
clinical course (exhibited in ~90% of the 85% RR-MS), followed by 
progression with or without occasional relapses, minor remissions 
and plateaus.
-   primary-progressive MS (PP-MS) – the disease with progression from 
onset, with plateaus and temporary minor improvements (~10%) (1, 
3, 4, 10). 
Because of the cross-sectional design of most studies on MS, clinical 
course is often more simply categorized into RR-MS, SP-MS and PP-MS (7, 
11). This categorization of clinical course will be used in this thesis.
The burden of disability in the cross-sectional design of MS 
studies is most frequently presented as the Kutzke Expanded Disability 
Status Score. Disability due to MS can be measured within functional 
neurological systems (pyramidal, cerebellar, brainstem, sensory, bowel 9
and bladder, visual, other) by assigning each a score. The distribution of 
the scores over the functional systems combined with their degree is then 
assigned to one of 20 categories (0, 0.5, 1, 1.5, 2,…10), which indicate the 
level of disability (12). 
1.1.3 Treatment
Patients with MS face enormous prognostic uncertainty, and they 
should become well informed about their illness. Treatment focuses on 
acute attacks, prevention of relapses and progression, management of 
symptoms, and rehabilitation. In recent years advances have been made 
in all four areas (13). Treating physicians have to continually assess the 
need for psychological support for patients and their families. 
Corticosteroid therapy is often used to treat clinically signiﬁ  cant 
relapses in an attempt to stop the relapse and consequently to 
hasten recovery. Current therapeutic agents for MS patients are 
anti-inﬂ   ammatory or immunomodulatory in nature (1, 4). Treatment 
with interferon-beta and glatiramer acetate may delay the development 
of a second, diagnosis-deﬁ   ning bout. Interferon-beta may delay the 
progression of disability in patients with minor disability who have 
a relapsing form of MS (3, 4, 14). The advent of natalizumab for the 
treatment of multiple sclerosis opens up a new era of immune-speciﬁ  c 
therapy. At present, the available therapeutic repertoire to ﬁ  ght against 
multiple sclerosis remains limited and is primarily aimed at targeting 
the activity of the immunocompetent cells (4, 15, 16).
Unfortunately, no proven therapies for PP-MS exist which would be 
able to reverse the neurological disabilities in MS patients (4). There are, 
however, moderately effective treatments for several of the complications 
of MS, like fatigue, pain, gait problems, spasticity, speech and swallowing 
disorders, weakness of legs, bladder and bowel disturbances, sexual 
dysfunction, cerebellar tremor, sleep disorders, cognitive and mood 
disorders, etc. (3, 4). 
1.1.4 Prognosis
One limiting factor in determining the potential improvement in outcome 
with new therapies is the lack of a direct biomarker for disease outcome. 
Over 120 randomized clinical trials are currently underway in MS 
involving 30 agents or combinations of agents, so the outlook for better 
therapies in the future is hopeful. Advances in the understanding of the 
underlying mechanisms of MS are allowing a more focused approach 
to the development of the new therapies for MS patients (13). Research 
and clinical developments in the ﬁ  eld of multiple sclerosis appear to be 
very active and dynamic at present; it is therefore hoped that some of the 
promising compounds may broaden the still limited therapeutic arsenal 
for this disabling disease (16). 10 CHAPTER  1 10
1.2   Structure of health status 
When trying to explain the structure of health status, some questions on 
health can be raised: Is health the absence of disease symptoms? Is health 
the ability to work and carry out one’s role? Does health include emotional 
and spiritual components? What is optimal health? The answers to these 
questions might only approach an explanation of health, however, because 
there is not really consensus on the deﬁ  nition of health the content of 
which has changed over time (17, 18). 
The concept of health as well-being was introduced in the World 
Health Organization (WHO) as a deﬁ  nition of health as “a state of complete 
physical, mental, and social well-being and not merely the absence of 
disease or inﬁ  rmity” (19). Other authors have characterized well-being 
as being able to feel well during a life of mobility, enjoyment and social 
relationships (20), and as an optimal individual ﬁ  tness, so that one lives 
a full, creative life (21). The WHO deﬁ  nition also provides a popular 
consideration of several different dimensions of health, such as physical 
(structure and function), social, role, mental (emotional and intellectual) 
and general perceptions of health status (17, 19). An important feature of 
health is its dimensionality. Health has distinct components, as can be 
derived from the deﬁ  nition of health offered by the WHO (19, 22).
Figure 1 presents a graphic representation of the International 
Classiﬁ  cation of Functioning, Disability and Health (ICF) model formally 
endorsed as the “International classiﬁ   cation of impairment, disability and 
health” by WHO, in which health conditions interact with environmental 
and personal factors, and result in functioning or disability in one or more 
components or levels (23, 24).
Figure 1 WHO model of the International Classification of Functioning, Disability and Health (24)
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As a conceptual framework for disability studies, Nagi’s model 
from 1965 is well-known. When conceptualizing disability, he thought in 
terms of a four-stage sequential process: disease – physiological impairment 
– limitations in the physical and emotional dimensions – disability. Nagi’s 
model was modiﬁ  ed by Johnson and Wolinsky (1993), who used slightly 
different terminology in some instances. The four terms in their model 
were substituted: disease – disability – functional limitation – perceived health 
(25) (Figure 2). 
Figure 2 Conceptual model of disability by Johnson and Wolinsky (1993)
DISEASE
Atherosclerosis
Hypertension
Stroke
Rheumatic fever
Coronary heart 
disease
etc.
DISABILITY
Upper body 
disability
Lower body 
disability FUNCTIONAL 
LIMITATION
Basic activities of 
daily living
Household activities
Advanced activities 
of daily living
PERCEIVED 
HEALTH
Johnson and Wolinsky (1993) expected that all of the dimensions of 
health status affected an individual’s global perception of his or her health 
status. The concept of perceived health status may reﬂ  ect the transitional 
status of acute symptoms unrelated to the more stable inﬂ  uences  of 
chronic disease, disability and functional limitations. That is, perceived 
health can also be linked to a wider range of health status measures, and 
therefore is frequently used as a proxy for other physical and mental 
health status measures (22, 25). Knowledge of the underlying disease, 
recognition of physical disabilities and awareness of functional limitation 
affect perceived health status negatively (25). 
It is still under debate whether health, deﬁ  ned comprehensively, 
can be equated with quality of life, which is deﬁ  ned as a much broader 
concept than health. Quality of life and well-being represent subjective 
perceptions and expectations of individuals about their health. Perceived 
health status reﬂ  ects a complex of internalized calculations based on life 
experience and knowledge of disease causes and consequences, or the 
inﬂ  uences of chronic disease, disability and functional limitations (22, 23, 
25-32). 
Considering the outcome of MS, it is possible to conceptualize the 
consequences as lying on a continuum of outcome (Figure 3) running 12 CHAPTER  1
from disease through impairment, disability (activities) and handicap 
(participation) – formalized in the International Classiﬁ  cation  of 
Impairments, Disabilities and Handicaps (ICIDH) (33, 34). 
Figure 3 Outcome continuum in MS of the ICIDH (33, 34) 
Disease Impairment Disability Handicap Quality of life
Relapse rate Weakness Locomotor Physical-independence Well-being
MRI Sensory dysfunction Dexterity Mobility
Fatigue Personal care Occupation
Bladder/bowel dysfunction Reading Social integration
Imbalance Sexual function Economic
Visual loss
Cognitive decline
Physical illness, particularly in chronic disorders, can be considered 
as one of the main causes of a loss of access to valued resources and, 
consequently, of valued goals. Loss for the individual involves, for 
example, a loss of independence, a reduced social mobility, reduced 
capacity to work, exposure to pain, fatigue and threat of disﬁ  gurement 
(and eventually death) (35, 36). The impact of some speciﬁ  c MS disabilities 
on perceived health status has been studied. Therefore, we now have 
evidence conﬁ  rming that cognitive and emotional functions and chronic 
pain correlate particularly with the physical and mental domains 
of perceived health status, that depression and anxiety signiﬁ  cantly 
inﬂ  uence the mental domains of perceived health status especially, that 
bladder, bowel and sexual functioning are related to reduced quality of 
social functioning, and that fatigue has an important impact on perceived 
health status in MS patients (26, 30, 37-41). 
MS inﬂ  uences a wide range of social and personal dimensions in 
life. When a person has MS the whole family “is affected” as well. The 
family of MS patients are often the most immediate and obvious source 
of social support, and the development of MS has a signiﬁ  cant effect on 
family dynamics as a whole. Patients without family, living alone because 
they are single, separated, divorced or widowed, may have a sense of 
isolation and uncertainty about the formation of new relationships. They 
very often need high levels of physical assistance and emotional support. 
Moreover, the somatic symptoms involved in MS can cause the loss of 
current employment and reduce economic status (42-45). 
Measures that address impairment and disability have traditionally 
been referred to as measures of health status (34, 46). It has become 
common to describe the same dimensions of health status (i.e. impairment, 13
disability and handicap) as health-related quality of life measures. In this 
study the construct ‘perceived health status’ is preferred over the use 
of ‘quality of life’, which was more or less ‘fashionable’ during the last 
decade. The full SF-36 was originally designed as a generic indicator of 
health status in the chronically ill (47). Chapter 2 provides a description 
of other useful health status measures apart from the SF-36. For example, 
the Multiple Sclerosis Quality of Life 54 Questionnaire (MSQoL-54) 
was expanded from the original the SF-36 Health Survey by adding an 
additional 18 items that were thought by experts to be relevant for patients 
with MS (34, 48). Items from the SF-36 are also a part of the European 
Quality of Life Scale (EuroQoL-5D) (49-51). Therefore the SF-36 Health 
Survey represents the heart of this study with regard to the evaluating the 
health status of MS patients.
1.3   Aims of the study and research questions
The inﬂ  uence of MS on health status has been studied on an individual 
level. MS, along with its disease symptoms, inﬂ   uences the activity, 
participation and well-being of patients. The association between MS 
and social and personal participation in daily activities or with decreased 
work ability and economic status of whole families is strong. Interaction 
directions as evaluated in this thesis and arising from the theoretical 
background of health status, are depicted in Figure 4. 
Figure 4 Design of this thesis
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The main objectives of the thesis therefore include:
1)  To explore the relationships between psychosocial factors and 
perceived health status in MS patients,
2)    To study the outcomes in perceived physical and mental health 
summary scales as measured by the SF-36 in MS patients. 
The objectives led to the following general research questions (RQ):
1)   To review the literature focusing on the associations between disease 
duration, disability and perceived health status as measured by the 
SF-36, as well as the psychological well-being related to perceived 
health status in MS patients (Chapter 2).
2)   To explore the association between self-rated health and employment 
status in MS patients when controlling for age, gender, functional 
disability, disease duration and psychological well-being (Chapter3). 
3)   To investigate whether different levels of perceived social support 
are associated with different levels of perceived health status in MS 
patients (Chapter 4). 
4)   To clarify whether mastery is associated with functional disability 
and perceived health status in MS patients, and how such an 
association might function (Chapter 5). 
5)    To investigate the discrepancies in the association of depression 
and anxiety with perceived physical and mental health status, and 
whether these associations differ in younger (<45 years) and older 
(≥45 years) MS patients (Chapter 6). 
1.4   Structure of this thesis
The outline of this thesis provides a ﬁ  rst insight into the studies addressing 
the disease of multiple sclerosis, health status with its structure and the 
speciﬁ  c components of perceived health status in MS patients. 
In Chapter 2 of this study an overview is given of perceived health 
status as measured using the SF-36 Health Survey in recent studies. 
Chapter 3 will describe the association between self-rated health and 
employment status in MS patients. The ability to maintain one’s job often 
depends on the progression of disease, and therefore this study sees the 
subjective assessment of health as a very helpful indicator of the current 
health status for further work of MS patients. Good self-rated health 
in association with the ability to work will be studied, and this which 
association will be controlled for age, gender, functional disability, disease 
duration, depression and anxiety. 
Subsequently, Chapter 4 will report on social support as a predictor 
of perceived health status in MS patients. The health status of MS patients 
may be improved when patients receive social support from their 
environment. To study this point of view, we will investigate whether 15
social support from family, friends or signiﬁ  cant others associates with 
different levels of perceived physical and mental health status in MS 
patients independently from basic demographic variables and functional 
disability.
Chapter 5 explores the contribution of mastery and functional 
disability to perceived health status in MS patients. Next, we are interested 
in knowing whether younger MS patients (<45 years of age) differ in the 
evaluation of mastery and in their health status when compared to older 
MS patients (≥45 years of age).
In Chapter 6 the study takes into account the relationship between 
depression and anxiety and perceived health status in the total sample, 
and possible discrepancies in the levels of depression and anxiety in 
younger (<45 years) and older (≥45 years) MS patients as well. 
Finally, in Chapter 7 the main results of this study are summarized 
and discussed, and general conclusions, clinical implications and 
recommendations for future research are made. 
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Abstract 
This review of literature gives an overview of recent studies about 
perceived health status as measured by the SF-36 Health Survey in 
patients with multiple sclerosis. The SF-36 is one of the tools measuring 
health status in patients used in international research and clinical 
practice. It measures two main health concepts - physical and mental. 
The SF-36 represents a valid instrument able to detect differences in 
perceived health status in patients. A computer-aided search in Medline 
and PsycINFO resulted in 504 articles in English published from 1996 to 
August 2006. After the screening process on the basis of abstracts, 8 articles 
consisting of empirical studies remained in which perceived health status 
was evaluated using the SF-36 Health Survey. Seven studies focused on 
disability and perceived health status in the SF-36. Two studies focused 
on the relationship between depression and perceived health status. 
These studies showed that multiple sclerosis patients with low disability 
and minor depression scored signiﬁ  cantly better than patients with high 
disability and major depression in the SF-36 health dimensions. Gender 
seems to have no inﬂ  uence on perceived health status in multiple sclerosis 
patients. The longer the disease duration and the more severe the disease, 
the lower the patients scored in perceived health status. The more disabled, 
the more depressive and the older the patients, the poorer their perceived 
health status was. Health providers supporting appropriate treatment 
might pay more attention to more disabled and more depressive patients, 
with longer disease duration. Perceived health status can be a predictor 
of prognosis and intervention outcomes. The study shows the importance 
of measuring perceived health status in multiple sclerosis patients with 
implications for their quality of life and provision of care. 
Introduction
Previous studies report that Multiple Sclerosis (MS) patients have reduced 
quality of life compared with groups from the general population. A large 
number of studies show that MS has negative effects on both the physical 
and mental dimensions of health and quality of life (1-3). 
MS is a chronic autoimmune disease with an uncertain course, 
characterized by recurrent patches of inﬂ  ammation in optic nerves, brain 
and spinal cord. Symptoms begin between ages 20 and 50 years in 90% of 
cases, with the peak onset at age 33 years. It is the most common cause 
of neurological disability in young adults. It is thought to affect over 2 
million people worldwide (4, 5).
Perceived health status reﬂ   ects a complex of internalized 
calculations based on life experience and knowledge of disease causes 21
and consequences (6, 7). The concept of perceived health status represents 
the inﬂ  uences of chronic disease, disability and functional limitations (7). 
There is uncertainty in deﬁ  nitions in the studies focusing on health status. 
The researchers study the physical, mental and social domains of health 
and refer to “quality of life” (1, 2, 8-10), “well-being” (11, 12) or “self-rated 
health” (13,  14). Despite these interchangeable terms, perceived health 
status has been identiﬁ  ed as the closest in meaning to the self–assessment 
of health by patients, which allows measurement of the effect of treatment 
on their overall health-related quality of life, and prediction of other 
outcomes, including survival in patients with chronic diseases (15, 16). 
The SF-36 is evaluated as an appropriate instrument for measuring 
general health, and is not speciﬁ  c for any age, disease or treatment group 
(17). The SF-36 assesses 4 physical health domains and 4 mental health 
domains. This generic indicator allows comparison of the health status 
of chronic patients with different conditions, and can be a predictor of 
prognosis and intervention outcomes (17, 18). The beneﬁ  ts of using the 
SF-36 dimensions in clinical practice could be substantial, e.g. assessment 
of vitality may indicate exhaustion in MS patients (19).
Perceived health status in MS patients might be affected by disease 
duration (9). The study by Riazi et al (20) focused on using the SF-36 in 
patients with MS or Parkinson`s disease, and in the normal population. 
They found that cross-sectional studies could not deﬁ  ne changes in health 
status according to disease duration (20). 
Many neurological scales associated with impairment and disability 
can measure perceived health status in MS patients (8). When MS patients 
are compared to controls, they score signiﬁ  cantly lower than the general 
population controls in measures of disability (16, 21, 22). With progression 
in disability, physical functioning scales show decreases in perceived 
health status. As previous studies report, a higher level of disability has 
negative consequences on perceived health status in MS patients (8, 16, 
21, 22).
Patients with depression usually suffer from sadness, reduced vitality 
and fatigue. The symptoms include lower interest, less concentration, 
insomnia, less appetite, low self-evaluation and self-esteem with feelings 
of nothingness. Depression is often associated with anxiety in somatic 
patients. Anxiety often involves obsessive symptomatology, with tension, 
shakiness, exudation and distraction (23, 24). High depression and 
anxiety as well were found to be negatively associated with physical and 
mental health status (25-27). High rates of depression have been found 
more frequently in MS patients than in comparable groups in some 
studies. It is suggested that MS patients on average are more depressed 
than comparable groups (28, 29), but the literature is inconclusive (30, 31). 
In some studies depression shows one of the strongest links with lower 
scores in self-reported questionnaires, independent of the clinical course 22 CHAPTER  2
or disability status of MS patients (1, 32). Patients may develop depression 
later as an understandable reaction to learning they have a chronic disease 
and having to live with its consequences (25, 33). Statistically, as many as 
60% of patients with MS experience major depression with a suicide rate 
7.5 times that of the age-matched general population (33). The negative 
impact of depressive symptoms on perceived health status in MS patients 
has been demonstrated (34). 
Aims 
The aim of this study was to review the literature focusing on the 
associations between disease duration, disability and perceived health 
status as measured by the SF-36, as well as the psychological well-being 
related to perceived health status in MS patients. Since SF-36 has been 
widely used in clinical and epidemiological studies, the beneﬁ  ts of using 
the SF-36 and its eight dimensions could be substantial indicators for 
assessing the physical, mental or social domains in MS patients.
Methods
Search strategy and selection criteria
The computer-assisted literature search covered the years 1996 - August 
2006. This search focused on the Medline databases and PsycINFO 
psychological abstracts, and was performed with a combination of the 
keywords “multiple sclerosis”, “self-reported”, “self-evaluation”, “self-
perception”, “self rated”, “patient rated”, “patient perceive”. Our search 
resulted in 504 hits.
Of these 504 hits, the studies meeting the following inclusion and 
exclusion criteria are mentioned. Inclusion criteria were: primary studies 
focusing on perceived health status in MS patients, written in English, 
published in journals during the search span. The second step was to 
exclude, on the basis of their abstracts, publications focusing only on the 
psychometric properties of the measures. Studies with irrelevant content 
on the basis of their abstracts (focusing on health care services, treatment 
and biomedical background, and studies comparing MS patients with 
other chronic diseases) were excluded as well. Furthermore, case studies 
were omitted. Finally, one study was eliminated in which a self-rating 
scale on perceived health status was used, but not the SF-36. The reference 
list of reviewed articles resulted in 8 relevant publications (Table 1).23
Table 1 Results of the screening process
Screening steps Result Final Result
1 Medline and PsycINFO retrieval + 504 504
2 Excluded articles about measures - 32 472
3 Excluded for irrelevant content 
(health care services, treatment and biomedical background, and studies comparing 
MS patients with different chronic diseases)
- 459 13
4 Excluded case studies - 4 9
5 Excluded study not using SF-36 - 1 8
Instruments
Health measures
Within this review we concentrated on 8 studies measuring perceived 
health status in MS patients. All studies used as their main measure 
the Short Form-36 Health Survey (SF-36). This was originally designed 
as a generic indicator of health status for use in population surveys and 
evaluative studies of health policy. The SF-36 includes eight multi-item 
scales to measure the following eight dimensions: physical functioning 
(ten items), role limitation due to physical health (four items), bodily pain 
(two items), social functioning (two items), general mental health, covering 
psychological distress and well-being (ﬁ  ve items), role limitations due to 
emotional problems (three items), vitality, energy or fatigue (four items) 
and general health perceptions (ﬁ  ve items). In addition, one question 
covers change in health status over the past year (one item). All item 
scores are coded and transformed into a scale of 0 (poor health) to 100 
(optimal health). The SF-36 may be self-administered or used in personal 
or telephone interviews (8, 17). SF-36 correlations with similar measures 
are generally consistent with the predictions. Physical function, social 
function, role limitation-physical, current health and health distress scales 
distinguish between normal subjects and patients with varying symptom 
severity (35).
Apart from the SF-36, four of the eight studies used various measures 
of perceived health status. They include: the European Quality of Life Scale 
(EuroQoL-5D) which deﬁ  nes health in terms of ﬁ  ve dimensions (mobility, 
self-care, usual activities, pain/discomfort, anxiety/depression); the 
Sickness Impact Proﬁ   le (SIP) where higher scores represent greater 
disease-related dysfunction; the Multiple Sclerosis Quality of Life 54 
Questionnaire (MSQoL-54); and ﬁ   nally the Subjective Estimation of 
Quality of Life (SQoL) (16, 22, 36, 37).24 CHAPTER  2
Disability
The Kurtzke Expanded Disability Status Scale (EDSS) is the most 
frequently used measure of disability in MS patients. Each measured 
functional system is graded to the nearest possible grade, where 0 means 
normal grade, 6 means loss of function and V indicates an unknown 
abnormality. Disability caused by MS is measured on a continuum of 
0 (normal neurologic examination) to 10 (death due to MS) according 
to Kurtzke (38). The Ofﬁ  ce of Population Census and Surveys (OPCS) 
presents a disability scale used by a non-medically qualiﬁ  ed assistant in 
the study by Rothwell et al (16). OPCS presents a disability questionnaire 
based upon a national survey of disability in Great Britain. The scale is 
used to assess disability in thirteen areas. For each area, a severity score is 
recorded based on a series of judgements by people with disabilities and 
those caring for them. The severity categories range from 1 (least severe) 
to 10 (most severe) (39). The last checklist in the study by Isaakson et al 
(37), the Self Reported Impairment contains 15 signs of impairment, and 
patients report if they have no symptoms, moderate or severe, and if the 
symptoms are constant or ﬂ  uctuating (37).
Psychological well-being
The Beck Depression Inventory (BDI) is used with patients to explore 
feelings and attitudes relating to general depressive status and to verify the 
inﬂ  uence of depression on health status in disabled people. It evaluates 21 
symptoms of depression (36, 40). The Center for Epidemiological Studies-
Depression Scale (CES-D) is a 20-item self-report measure that yields a 
numerical estimate of depression severity (36, 41). In the both depression 
measures, higher scores indicate greater depression (36, 40, 41).
Statistics 
Correlation analyses examining the relationships between the study 
variables were used in all reviewed studies (3, 16, 21, 22, 34, 36, 37, 42). 
Unpaired t-tests were used to compare MS patients with the general 
population in one study (42). Univariate analyses were performed using 
the chi-square test for the proportions (22), and one-way ANOVA (22, 34, 
42), the Wilcoxon rank-sum test (22, 37) and Kruskal Wallis test (22) for 
continuous data. Linear regression analyses were used in three studies (3, 
21, 36), and logistic regression analysis in one study (22). 
Ethical issues
The reviewed studies were previously approved by the research ethics 
committees of the universities or institutes where they were performed (3, 
16, 21, 22, 34, 37, 42). Information is lacking only for one study (36).25
Results
Participants, sample size and measures
A total of 8 studies were found to meet the criteria for inclusion (Table 
2). The number of subjects varied between 42 and 261 MS patients. Six 
surveys were conducted in Europe and two in the USA. In one study 
data were obtained by postal questionnaires (22) and in one by telephone 
(36). In the six remaining studies data were collected during the patients’ 
clinic visits (3, 16, 21, 34, 37, 42). Selected studies were grouped into three 
categories according to the inﬂ  uence on perceived health status: the SF-36 
and disease duration, the SF-36 and disability, and ﬁ  nally the SF-36 and 
psychological determinants (Table 2).26 CHAPTER  2
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h
 
d
i
m
e
n
s
i
o
n
s
 
c
o
m
p
a
r
e
d
 
w
i
t
h
 
s
e
x
-
 
a
n
d
 
a
g
e
-
 
a
d
j
u
s
t
e
d
 
s
c
o
r
e
s
 
i
n
 
t
h
e
 
g
e
n
e
r
a
l
 
p
o
p
u
l
a
t
i
o
n
.
 
T
h
i
s
 
d
i
f
f
e
r
e
n
c
e
 
w
a
s
 
e
s
p
e
c
i
a
l
l
y
 
h
i
g
h
 
f
o
r
 
p
h
y
s
i
c
a
l
 
f
u
n
c
t
i
o
n
i
n
g
;
 
g
e
n
e
r
a
l
 
h
e
a
l
t
h
;
 
r
o
l
e
 
l
i
m
i
t
a
t
i
o
n
,
 
p
h
y
s
i
c
a
l
;
 
v
i
t
a
l
i
t
y
,
 
a
n
d
 
s
o
c
i
a
l
 
f
u
n
c
t
i
o
n
i
n
g
.
 
N
o
r
t
v
e
d
t
 
e
t
 
a
l
.
 
2
0
0
0
(
r
e
f
 
3
)
-
 
T
o
 
i
n
v
e
s
t
i
g
a
t
e
 
t
h
e
 
p
r
e
d
i
c
t
i
v
e
 
v
a
l
u
e
 
o
f
 
S
F
-
3
6
 
l
i
k
e
 
m
e
a
s
u
r
e
 
o
f
 
q
u
a
l
i
t
y
 
o
f
 
l
i
f
e
 
o
n
 
c
h
a
n
g
e
s
 
i
n
 
d
i
s
a
b
i
l
i
t
y
.
-
 
D
a
t
a
 
f
r
o
m
 
9
7
 
r
e
l
a
p
s
e
-
r
e
m
i
t
t
i
n
g
 
p
a
t
i
e
n
t
s
 
w
i
t
h
 
M
S
 
f
r
o
m
 
r
a
n
d
o
m
i
s
e
d
,
 
d
o
u
b
l
e
-
b
l
i
n
d
,
 
p
l
a
c
e
b
o
-
c
o
n
t
r
o
l
l
e
d
 
c
l
i
n
i
c
a
l
 
t
r
i
a
l
 
o
f
 
r
e
c
o
m
b
i
n
a
n
t
 
h
u
m
a
n
 
i
n
t
e
r
f
e
r
o
n
 
-
2
a
,
 
N
o
r
w
a
y
-
 
T
h
e
 
K
u
r
t
z
k
e
 
E
x
p
a
n
d
e
d
 
D
i
s
a
b
i
l
i
t
y
 
S
t
a
t
u
s
 
S
c
a
l
e
 
E
D
S
S
,
 
S
F
-
3
6
 
H
e
a
l
t
h
 
S
u
r
v
e
y
,
 
g
a
d
o
l
i
n
i
u
m
-
e
n
h
a
n
c
e
d
 
M
R
I
-
 
L
o
n
g
i
t
u
d
i
n
a
l
;
 
f
o
l
l
o
w
-
u
p
 
1
 
y
e
a
r
 
l
a
t
e
r
-
 
A
f
t
e
r
 
1
 
y
e
a
r
:
 
-
 
M
H
 
 
E
D
S
S
 
r
=
 
-
.
2
9
*
*
-
 
E
R
L
 
 
E
D
S
S
 
r
=
 
-
.
2
2
*
 
-
 
L
o
w
 
s
c
o
r
e
s
 
o
n
 
S
F
-
3
6
 
m
e
n
t
a
l
 
h
e
a
l
t
h
 
s
c
a
l
e
 
w
e
r
e
 
c
o
r
r
e
l
a
t
e
d
 
w
i
t
h
 
i
n
c
r
e
a
s
e
d
 
E
D
S
S
 
s
c
o
r
e
s
 
1
 
y
e
a
r
 
l
a
t
e
r
;
 
t
h
e
 
r
e
s
u
l
t
s
 
w
e
r
e
 
n
o
t
 
a
l
t
e
r
e
d
 
b
y
 
a
d
j
u
s
t
i
n
g
 
f
o
r
 
d
i
s
e
a
s
e
 
a
c
t
i
v
i
t
y
 
a
t
 
b
a
s
e
l
i
n
e
,
 
w
h
i
c
h
 
w
a
s
 
m
e
a
s
u
r
e
d
 
b
y
 
t
h
e
 
n
u
m
b
e
r
 
g
a
d
o
l
i
n
i
u
m
-
e
n
h
a
n
c
e
d
 
M
R
I
 
l
e
s
i
o
n
s
,
 
r
e
l
a
p
s
e
 
r
a
t
e
 
f
o
r
 
t
h
e
 
p
r
e
c
e
d
i
n
g
 
2
 
y
e
a
r
s
,
 
a
n
d
 
b
a
s
e
l
i
n
e
 
E
D
S
S
 
s
c
o
r
e
.
 
-
 
A
 
h
i
g
h
 
s
c
o
r
e
 
o
f
 
s
e
l
f
-
r
a
t
e
d
 
h
e
a
l
t
h
 
(
1
s
t
 
q
u
e
s
t
i
o
n
 
i
n
 
t
h
e
 
S
F
-
3
6
)
 
a
t
 
b
a
s
e
l
i
n
e
 
w
a
s
 
c
o
r
r
e
l
a
t
e
d
 
w
i
t
h
 
t
h
e
 
d
e
c
r
e
a
s
e
d
 
E
D
S
S
 
s
c
o
r
e
 
a
f
t
e
r
 
1
 
y
e
a
r
.
 28 CHAPTER  2
D
i
s
a
b
i
l
i
t
y
 
 
S
F
-
3
6
 
A
u
t
h
o
r
S
t
u
d
y
 
a
i
m
S
a
m
p
l
e
,
 
M
e
a
s
u
r
e
s
 
a
n
d
 
S
t
u
d
y
 
d
e
s
i
g
n
 
R
e
s
u
l
t
s
M
a
i
n
 
F
i
n
d
i
n
g
s
S
o
l
a
r
i
 
 
R
a
d
i
c
e
 
2
0
0
1
(
r
e
f
 
2
2
)
-
 
T
o
 
a
s
s
e
s
s
 
t
h
e
 
p
e
r
c
e
i
v
e
d
 
h
e
a
l
t
h
 
s
t
a
t
u
s
 
o
f
 
p
e
o
p
l
e
 
w
i
t
h
 
M
S
.
-
 
4
0
0
 
p
e
o
p
l
e
 
w
i
t
h
 
M
S
,
 
2
6
1
 
r
e
s
p
o
n
d
e
n
t
s
,
 
r
a
n
d
o
m
l
y
 
s
e
l
e
c
t
e
d
 
i
n
 
P
r
o
v
i
n
c
e
 
o
f
 
M
i
l
a
n
 
a
n
d
 
L
o
m
b
a
r
d
y
 
R
e
g
i
o
n
a
l
 
H
e
a
l
t
h
 
S
e
r
v
i
c
e
,
 
I
t
a
l
y
-
 
P
o
s
t
a
l
 
q
u
e
s
t
i
o
n
n
a
i
r
e
s
 
-
 
t
h
e
 
M
u
l
t
i
p
l
e
 
S
c
l
e
r
o
s
i
s
 
Q
u
a
l
i
t
y
-
o
f
-
L
i
f
e
 
5
4
 
Q
u
e
s
t
i
o
n
n
a
i
r
e
 
(
M
S
Q
O
L
-
5
4
)
,
 
S
F
-
3
6
 
H
e
a
l
t
h
 
S
u
r
v
e
y
,
 
s
t
r
u
c
t
u
r
e
d
 
d
e
m
o
g
r
a
p
h
i
c
 
a
n
d
 
c
l
i
n
i
c
a
l
 
q
u
e
s
t
i
o
n
n
a
i
r
e
-
 
C
r
o
s
s
-
s
e
c
t
i
o
n
a
l
 
s
t
u
d
y
-
 
P
F
 
(
z
=
 
-
1
.
3
)
 
a
n
d
 
P
R
L
 
 
 
 
(
z
=
 
-
.
9
)
 
m
o
s
t
 
d
i
s
t
i
n
g
u
i
s
h
e
d
 
 
 
 
 
t
h
e
 
g
r
o
u
p
s
-
 
T
h
e
 
t
h
r
e
e
 
M
S
 
g
r
o
u
p
s
 
(
E
D
S
S
<
4
.
0
;
 
4
.
0
-
6
.
5
;
 
>
6
.
5
)
 
d
i
f
f
e
r
e
d
 
s
i
g
n
i
f
i
c
a
n
t
l
y
 
f
o
r
 
a
l
l
 
d
o
m
a
i
n
s
 
e
x
c
e
p
t
 
c
o
g
n
i
t
i
v
e
 
a
n
d
 
s
e
x
u
a
l
 
f
u
n
c
t
i
o
n
s
.
 
-
 
C
o
m
p
a
r
i
s
o
n
s
 
b
e
t
w
e
e
n
 
t
h
e
 
g
e
n
e
r
a
l
 
p
o
p
u
l
a
t
i
o
n
 
S
F
-
3
6
 
s
c
a
l
e
s
 
a
n
d
 
t
h
e
 
E
D
S
S
 
4
.
0
-
6
.
5
 
a
n
d
 
t
h
e
 
E
D
S
S
 
>
 
6
.
5
 
g
r
o
u
p
s
 
a
r
e
 
h
i
g
h
l
y
 
s
i
g
n
i
f
i
c
a
n
t
 
f
o
r
 
a
l
l
 
S
F
-
3
6
 
s
c
a
l
e
s
.
 
P
a
t
i
e
n
t
s
 
h
a
d
 
l
o
w
e
r
 
s
c
o
r
e
s
 
t
h
a
n
 
t
h
e
 
g
e
n
e
r
a
l
 
p
o
p
u
l
a
t
i
o
n
.
 
-
 
T
h
e
 
E
D
S
S
 
<
4
.
0
 
g
r
o
u
p
 
d
i
f
f
e
r
s
 
s
i
g
n
i
f
i
c
a
n
t
l
y
 
i
n
 
a
 
p
o
s
i
t
i
v
e
 
w
a
y
 
o
n
l
y
 
f
o
r
 
g
e
n
e
r
a
l
 
h
e
a
l
t
h
 
a
n
d
 
s
o
c
i
a
l
 
f
u
n
c
t
i
o
n
.
 
M
S
 
p
o
p
u
l
a
t
i
o
n
 
s
c
o
r
e
d
 
w
o
r
s
e
 
t
h
a
n
 
t
h
e
 
g
e
n
e
r
a
l
 
p
o
p
u
l
a
t
i
o
n
 
i
n
 
a
l
l
 
d
o
m
a
i
n
s
.
 
I
s
a
k
s
s
o
n
e
t
 
a
l
.
 
2
0
0
5
(
r
e
f
 
3
7
)
-
 
T
o
 
d
e
s
c
r
i
b
e
 
q
u
a
l
i
t
y
 
o
f
 
l
i
f
e
 
i
n
 
M
S
 
p
a
t
i
e
n
t
s
 
g
i
v
e
n
 
i
m
m
u
n
o
l
o
g
i
c
a
l
 
t
r
e
a
t
m
e
n
t
 
 
n
o
n
-
i
m
m
u
n
o
l
o
g
i
c
a
l
 
t
r
e
a
t
m
e
n
t
,
 
t
o
 
i
n
v
e
s
t
i
g
a
t
e
 
t
h
e
 
r
e
l
a
t
i
o
n
s
h
i
p
 
b
e
t
w
e
e
n
 
i
m
p
a
i
r
m
e
n
t
 
a
n
d
 
q
u
a
l
i
t
y
 
o
f
 
l
i
f
e
.
-
 
2
9
 
M
S
 
p
a
t
i
e
n
t
s
 
w
i
t
h
 
i
m
m
u
n
o
l
o
g
i
c
a
l
 
t
r
e
a
t
m
e
n
t
 
w
e
r
e
 
m
a
t
c
h
e
d
 
w
i
t
h
 
2
9
 
M
S
 
p
a
t
i
e
n
t
s
 
n
o
t
 
g
i
v
e
n
 
s
u
c
h
 
t
r
e
a
t
m
e
n
t
,
 
S
w
e
d
e
n
-
 
S
e
l
f
-
r
e
p
o
r
t
e
d
 
i
m
p
a
i
r
m
e
n
t
 
c
h
e
c
k
l
i
s
t
,
 
S
F
-
3
6
 
H
e
a
l
t
h
 
S
u
r
v
e
y
,
 
t
h
e
 
S
u
b
j
e
c
t
i
v
e
 
E
s
t
i
m
a
t
i
o
n
 
o
f
 
Q
u
a
l
i
t
y
 
o
f
 
L
i
f
e
 
S
Q
o
L
-
 
C
r
o
s
s
-
s
e
c
t
i
o
n
a
l
 
s
t
u
d
y
 
w
i
t
h
 
m
a
t
c
h
e
d
 
p
a
i
r
s
-
 
E
D
S
S
 
 
P
F
 
r
=
.
6
2
-
 
E
D
S
S
 
 
B
P
,
 
G
H
,
 
 
 
 
 
S
F
,
 
P
R
L
 
r
=
 
.
2
8
,
 
 
 
r
=
 
-
.
3
5
-
 
I
n
 
t
h
e
 
w
h
o
l
e
 
g
r
o
u
p
 
o
f
 
M
S
 
p
a
t
i
e
n
t
s
,
 
s
t
a
t
i
s
t
i
c
a
l
l
y
 
s
i
g
n
i
f
i
c
a
n
t
 
c
o
r
r
e
l
a
t
i
o
n
 
b
e
t
w
e
e
n
 
E
D
S
S
 
a
n
d
 
 
6
 
v
a
r
i
a
b
l
e
s
 
o
f
 
t
h
e
 
S
F
-
3
6
 
w
e
r
e
 
f
o
u
n
d
.
-
 
P
h
y
s
i
c
a
l
 
f
u
n
c
t
i
o
n
i
n
g
 
w
a
s
 
a
s
s
o
c
i
a
t
e
d
 
w
i
t
h
 
w
a
l
k
i
n
g
 
p
r
o
b
l
e
m
s
,
 
s
p
a
c
t
i
c
i
t
y
 
a
n
d
 
b
a
l
a
n
c
e
.
-
 
T
h
e
 
p
h
y
s
i
c
a
l
 
r
o
l
e
 
l
i
m
i
t
a
t
i
o
n
s
 
w
e
r
e
 
a
s
s
o
c
i
a
t
e
d
 
w
i
t
h
 
w
a
l
k
i
n
g
,
 
f
a
t
i
g
u
e
,
 
c
o
n
c
e
n
t
r
a
t
i
o
n
/
p
o
o
r
 
m
e
m
o
r
y
.
-
 
P
a
i
n
,
 
f
a
t
i
g
u
e
,
 
a
n
d
 
c
o
n
c
e
n
t
r
a
t
i
o
n
 
h
a
d
 
t
h
e
 
h
i
g
h
e
s
t
 
i
m
p
a
c
t
 
o
n
 
 
v
i
t
a
l
i
t
y
,
 
s
o
c
i
a
l
 
f
u
n
c
t
i
o
n
i
n
g
 
a
n
d
 
m
e
n
t
a
l
 
h
e
a
l
t
h
 
i
n
 
t
h
e
 
w
h
o
l
e
 
g
r
o
u
p
.29
P
s
y
c
h
o
l
o
g
i
c
a
l
 
d
e
t
e
r
m
i
n
a
n
t
s
 
 
S
F
-
3
6
 
A
u
t
h
o
r
S
t
u
d
y
 
a
i
m
S
a
m
p
l
e
,
 
M
e
a
s
u
r
e
s
 
a
n
d
 
S
t
u
d
y
 
d
e
s
i
g
n
 
R
e
s
u
l
t
s
M
a
i
n
 
F
i
n
d
i
n
g
s
R
o
t
h
w
e
l
l
 
e
t
 
a
l
.
 
1
9
9
7
(
r
e
f
 
1
6
)
-
 
T
o
 
c
o
m
p
a
r
e
 
t
h
e
 
p
e
r
c
e
p
t
i
o
n
s
 
o
f
 
M
S
 
p
a
t
i
e
n
t
s
 
(
a
n
d
 
c
l
i
n
i
c
i
a
n
s
)
 
a
s
 
t
o
 
t
h
e
 
r
e
l
a
t
i
v
e
 
i
m
p
o
r
t
a
n
c
e
 
o
f
 
t
h
e
 
8
 
d
i
f
f
e
r
e
n
t
 
d
o
m
a
i
n
s
 
o
f
 
t
h
e
 
S
h
o
r
t
 
F
o
r
m
 
3
6
-
 
4
2
 
M
S
 
p
a
t
i
e
n
t
s
 
(
2
8
 
-
 
6
8
 
y
e
a
r
s
)
 
a
n
d
 
c
o
n
t
r
o
l
 
d
a
t
a
 
f
r
o
m
 
s
u
r
v
e
y
 
o
f
 
h
e
a
l
t
h
 
r
e
l
a
t
e
d
 
q
u
a
l
i
t
y
 
o
f
 
l
i
f
e
 
i
n
 
o
v
e
r
 
6
0
0
0
 
p
e
o
p
l
e
 
i
n
 
1
9
9
3
,
 
U
K
-
 
S
F
-
3
6
 
H
e
a
l
t
h
 
S
u
r
v
e
y
;
 
E
u
r
o
Q
o
L
-
5
D
;
 
K
u
r
t
z
k
e
 
E
x
p
a
n
d
e
d
 
D
i
s
a
b
i
l
i
t
y
 
S
t
a
t
u
s
 
S
c
a
l
e
 
E
D
S
S
;
 
t
h
e
 
O
f
f
i
c
e
 
o
f
 
P
o
p
u
l
a
t
i
o
n
 
C
e
n
s
u
s
 
a
n
d
 
S
u
r
v
e
y
`
s
 
(
O
P
C
S
)
 
d
i
s
a
b
i
l
i
t
y
 
s
t
a
t
u
s
 
s
c
a
l
e
-
 
C
r
o
s
s
-
s
e
c
t
i
o
n
a
l
 
s
t
u
d
y
-
 
V
 
 
E
u
r
o
Q
o
L
 
r
=
.
 
5
7
*
*
*
 
-
 
G
H
 
 
 
E
u
r
o
Q
o
L
 
 
 
r
=
.
 
4
9
*
*
*
 
-
 
M
H
 
 
E
u
r
o
Q
o
L
 
 
 
r
=
 
.
4
4
*
*
-
 
P
a
t
i
e
n
t
s
`
 
a
s
s
e
s
s
m
e
n
t
 
o
f
 
t
h
e
i
r
 
p
h
y
s
i
c
a
l
 
d
i
s
a
b
i
l
i
t
y
 
w
a
s
 
h
i
g
h
l
y
 
c
o
r
r
e
l
a
t
e
d
 
w
i
t
h
 
t
h
e
 
c
l
i
n
i
c
i
a
n
s
’
 
a
s
s
e
s
s
m
e
n
t
 
a
n
d
 
t
h
e
 
n
o
n
-
c
l
i
n
i
c
a
l
 
a
s
s
e
s
s
m
e
n
t
.
 
Q
u
a
l
i
t
y
 
o
f
 
l
i
f
e
 
(
E
u
r
o
Q
o
L
-
5
D
)
 
c
o
r
r
e
l
a
t
e
d
 
w
i
t
h
 
v
i
t
a
l
i
t
y
,
 
g
e
n
e
r
a
l
 
h
e
a
l
t
h
,
 
a
n
d
 
m
e
n
t
a
l
 
h
e
a
l
t
h
 
i
n
 
t
h
e
 
S
F
-
3
6
,
 
e
a
c
h
 
o
f
 
w
h
i
c
h
 
p
a
t
i
e
n
t
s
 
r
a
t
e
d
 
a
s
 
m
o
r
e
 
i
m
p
o
r
t
a
n
t
 
t
h
a
n
 
c
l
i
n
i
c
i
a
n
s
;
 
e
a
c
h
 
p
a
t
i
e
n
t
 
s
c
o
r
e
d
 
l
o
w
e
r
 
t
h
a
n
 
t
h
e
 
c
o
n
t
r
o
l
s
.
S
c
h
w
a
r
t
z
 
 
K
r
a
f
t
 
1
9
9
9
(
r
e
f
 
3
6
)
-
 
T
o
 
a
s
s
e
s
s
 
M
S
 
p
a
t
i
e
n
t
s
’
 
d
i
s
a
b
i
l
i
t
y
 
b
e
h
a
v
i
o
u
r
 
a
n
d
 
i
t
s
 
i
m
p
a
c
t
 
o
n
 
p
a
t
i
e
n
t
 
p
s
y
c
h
o
l
o
g
i
c
a
l
 
a
n
d
 
p
h
y
s
i
c
a
l
 
f
u
n
c
t
i
o
n
i
n
g
 
i
n
 
a
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Note:
*p<.05;  **p<.01;  ***p<.001; SF-36 subscales mentioned in Table: V=vitality, MH=mental health, 
ERL=emotional role limitation, SF=social functioning, PF=physical functioning, GH=general health, 
PRL=physical role limitation; BP=bodily pain, higher scores indicate “better functioning”; Dis Dur=disease 
duration; EuroQoL=quality of life, higher scores indicate “better health”; D=depression measured with BDI 
or CES-D, higher scores indicate “greater depression”; EDSS=Kurtzke Expanded Disability Status Scale, 
0=normal neurologic examination to 10=death due to MS
Disease duration and perceived health status
Health dimensions in SF-36 were negatively correlated with the time 
since diagnosis. The longer the disease duration, the more severe the 
disease, and the lower the patients scored in perceived health status (34). 
Patients with an intermediate time since diagnosis (6-10 years) scored 
worse than patients with the shortest time since diagnosis (<6 years) 
for physical functioning, role limitation, bodily pain, vitality, emotional 
role and mental health. There was no signiﬁ  cant difference between the 
patients with disease duration of over 10 years and those with the disease 
lasting 6-10 years (34) (Table 3). Compared to the general population 
and a group of MS patients with whatever disease duration, the patients 
with a short time since diagnosis (<6 years) already scored worse in all 
health dimensions in SF-36, except for bodily pain (34) (Table 3). Physical 
functioning in the SF-36 negatively and signiﬁ   cantly correlated with 
duration of MS from onset (r = -0.37; p<0.001) (42) (Table 2).
Disability and perceived health status
Four studies examined the association between disease severity groups 
and the dimensions of the SF-36. The scores on both the EDSS and the 
OPCS were highly correlated with physical functioning measured by MS 
patients on the SF-36 (16). The MS patients with the least disability had 
a lower mean score than the general population in all health dimensions 
of the SF-36 (34), except for mental health in the study by Nortvedt et al 
(21), and explicitly for general health and social functioning in the study 
by Solari & Radice (22). Similarly, the MS groups with higher disability 
differed highly signiﬁ  cantly for all SF-36 scales compared with the general 
population (22, 42) (Table 2). 
The MS patients in the study by Nortvedt et al (21) were categorized 
into three EDSS severity groups (Table 3). The patients with low EDSS 
results scored signiﬁ  cantly better than the two groups with higher EDSS 
scores in all SF-36 dimensions. The SF-36 scores were higher in the groups 
with EDSS scores between 3.0 and 6.0 than in patients with the highest 
EDSS scores for physical functioning and social functioning. The EDSS 
score explained 73% of the variation in physical functioning, 23% in social 
functioning, and 21% in general health (21).31
The study by Patti et al (34) showed that patients with lower EDSS 
scores scored signiﬁ  cantly better than the two groups with higher EDSS 
scores in all dimensions. The patients with EDSS scores of 3.0 - 6.0 had 
higher scores on the SF-36 than the patients with the highest EDSS score 
only for physical functioning (34) (Table 3).
In the study by Pittock et al (42) the dimensions of physical 
functioning, physical role, general health, social functioning and vitality 
were signiﬁ  cantly correlated with the EDSS score (42). Isaksson et al (37) 
found almost the same results. In their study a group of MS patients 
given immunological treatment was compared to a group not given this 
treatment. Between the two groups no signiﬁ  cant differences were found 
with regard to perceived health status. However, signiﬁ  cant correlations 
were found between disability and six subscales of the SF-36. As they 
expected, physical functioning, but also bodily pain, general health, social 
functioning, physical role limitation and emotional role limitation were 
correlated with the EDSS in the whole group (37) (Table 2). 
With regard to change in disability, the change in EDSS score one 
year later reﬂ   ects a more progressive disease at baseline among the 
patients with low scores on the mental health scale. All other subscales 
were not signiﬁ  cantly correlated in this respect (3) (Table 2). 
Psychological well-being and perceived health status
Rothwell  et al (16) focused on the dimensions in EuroQoL-5D question-
naires where the depression/anxiety subscale was related to perceived 
health status as measured by the SF-36. The anxiety and depression scale, 
moreover, correlated signiﬁ  cantly with vitality, general health, mental 
health, and physical role limitation in the SF-36 (16) (Table 2).
Schwartz & Kraft (36) examined the relationship between patients’ 
ratings of their spouses’ responses to disability behaviors of MS patients 
and the impact on patients psychological and physical functioning. 
Depression was measured using CES-D, and no signiﬁ  cant relationship 
was found between depression and the physical dimension of SF-36, 
although depression was related signiﬁ  cantly with physical functioning 
as measured by the SIP (36) (Table 2). 
Patti et al (34) investigated the relationship between the SF-36 and 
depression as well. MS patients with lower BDI scores had a lower SF-36 
mean score in all dimensions except for bodily pain. These patients with 
lower scores on depression scored signiﬁ  cantly better than the two groups 
with higher BDI scores in all SF-36 health dimensions. The patients with 
BDI scores from 11-17 had higher SF-36 scores than the patients with the 
highest BDI scores for physical functioning, role emotional and mental 
health, and they had lower scores in all SF-36 health dimensions than the 
patients with the lowest BDI scores. BDI showed high partial correlations 
with all SF-36 health dimensions. The highest coefﬁ  cient was for mental 
health as measured by the SF-36 (34) (Table 3).32 CHAPTER  2
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Discussion
The objective of this study was to review and summarize existing literature 
regarding perceived health status in MS patients measured with the 
SF-36 Health Survey, with the focus on disability, disease duration and 
psychological well-being. 
The SF-36 was selected as the key measure in this review. Although 
it was originally designed as a generic measure in population surveys, 
the reviewed studies conﬁ  rmed the SF-36 as an appropriate and useful 
measure of perceived health status in MS patients (3, 16, 21, 22, 34, 36, 37, 
42). As most of the instruments in the reviewed studies used ordinal scales, 
statistics in these studies were mainly performed with using correlation 
analyses, while some of them used ANOVA and others regression analyses. 
Causal relationships would need to be conﬁ  rmed in an intervention study. 
It follows that these studies‘ ﬁ  ndings should be used for evaluation of 
health status in MS patients in the treatment process (3).
The results of our review show that time since diagnosis negatively 
inﬂ  uences perceived health status measured with the SF-36 in patients 
with MS. After some time from baseline, patients’ perceived health status 
worsens, possibly as a consequence of increasing disability. MS patients 
with longer disease duration have more physical difﬁ  culties than patients 
with short time from diagnosis. Worsened disability interlocks the mental 
and other growing symptoms after some time (40). It might be assumed that 
longer disease duration would be associated with worsening of physical 
functioning, although only a few studies focus on the association between 
disease duration and perceived health status in MS patients (34, 42).
A majority of the studies in this review investigated the relationship 
between disability and perceived health status as measured with the SF-36. 
Those patients with higher scores in disability assessed their health status 
as worse, especially in physical functioning. Disability inﬂ  uenced mostly 
perceived physical health, but determined other dimensions of perceived 
health status in MS as well. Disability usually changed after some time. 
EDSS change correlated with the mental health subscale of SF-36 after 
one year and it was potentially predictive. This may be important in 
comparing physical health status of MS patients with different conditions 
or in comparing the same patients after some time. The outcomes in the 
physical health status domains may predict disease severity and the 
following intervention. In the report by Haupts et al (43) the reductions in 
the eight subscales of SF-36 were even more pronounced in persons with 
gait impairments. In their study the SF-36 scales only modestly correlated 
with physical disability. In contrast to Nortverdt et al (21) this indicates 
that perceived health status does not depend on the physical symptoms 
of MS (43). 34 CHAPTER  2
Patti et al (44) demonstrate that disability can be improved by using 
short outpatient physiotherapy treatment. Treatments in MS are directed 
at resolving acute attacks, reducing the number of exacerbations, treating 
the sequels of previous attacks, and preventing progression of disability 
(44).
Regarding psychological well-being and perceived health status, the 
latter was better in the patients with less depression (34). MS-depressed 
patients scored worse on the energy, mental health, cognitive function, 
overall quality of life, sexual and emotional function dimensions than 
non-depressed MS patients (10). The study by Benito-Leon et al (45) 
showed that MS patients currently experiencing depression would give 
a more negative evaluation of their well-being than those who were not 
depressed, whether or not a physical illness was also present. There will 
be some overlap between ratings of low mood and quality of life (45). 
According to Lamberg (33), depression shows little correlation with 
deﬁ  cits in cognitive function, suggesting that it may be an independent 
indicator of neurological damage. Lamberg (33) complements treatments 
with cognitive-behavioural, group and family therapy, and the use of 
antidepressant medications that improve mood and whole perceived 
health status. MS patients in the study by Schwartz & Kraft (36) who rated 
their spouses as more negative in response to their disability behaviours 
had more symptoms of depression. Those MS patients who reported their 
spouses as more encouraging of “well” behaviours were signiﬁ  cantly less 
depressed. Spousal support had a buffering effect against depression 
in MS patients. MS patients‘ depressive symptoms were found to have 
a moderating affect on the relationship between patients‘ ratings of 
spouses‘ responses and patients‘ physical functioning (36). Regarding 
these ﬁ   ndings Rudick (4) sees comprehensive MS centers as being 
extremely helpful to MS patients and their families.
The results of this review may identify potential targets for practice 
interventions in MS patients. Perceived health status is like a mirror of 
the way the patient feels about and copes with the disease. Findings 
from the subscales of SF-36 can be used for observation of MS patients’ 
health status, especially of their disability, as time passes, or psychological 
symptoms when they are more depressed, anxious or stressed. Sometimes 
physicians evaluate MS patients as suffering from a handicap from the 
loss of motor function. But the patients can be distressed more from the 
cognitive impairment, bad emotional functioning or the loss of social 
relationships. Assessments of the health professionals do not have to 
agree with the internal information from MS patients about their health 
status. For the patients their own perceptions are of higher importance 
(46). It may be useful to determine the impairments of MS patients using 
this measurement, and based on its results to recommend appropriate 
interventions in the practice of nurses, psychologists or physiotherapists. 35
The SF-36 proﬁ   le improved for those patients who underwent 
physiotherapy (10, 34). Nursing care should be part of a continuum of 
care involving the physiotherapy environment and community and social 
services sectors. 
Conclusions
This study is a review of previous studies examining the association of 
perceived health status with disability, disease duration and psychological 
well-being in cohorts of MS patients. We assumed that disease duration, 
disability and psychological well-being would be signiﬁ  cantly associated 
with perceived health status in MS patients measured with the SF-36 
in the eight reviewed studies. This review provided evidence for this 
hypothesis. The more disabled the patients, the poorer their perceived 
health status. One study showed MS patients already reporting poorer 
health status than the general population after very short duration of 
MS. Perceived health status also signiﬁ  cantly correlated with depression: 
the more depressed the patients, the worse their perceived health status 
was. Further research should focus on strategies to improve perceived 
health status in MS patients. Our ﬁ  ndings may be useful for evaluating 
the impairments of MS patients, and for determining the appropriateness 
of treatment in the practice of nurses, psychologists or physiotherapists. 
Health care, looking for appropriate treatments, could pay more attention 
to perceived health status in MS patients by focusing on improved quality 
of life in these patients. The SF-36 data could be useful, if its results 
were validated in relation to ﬁ  ndings from other speciﬁ  c self-reported 
instruments used not only in MS, but in other chronic diseases. So the 
SF-36 outcomes can be important when compared with data from other 
self-reported measures used in clinical practice.
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Abstract 
The aim is to explore the association between self-rated health and 
employment status in multiple sclerosis (MS) patients when controlling 
for age, gender, functional status, disease duration, anxiety and 
depression. 184 MS patients completed a sociodemographic questionnaire 
that included questions on employment status, the ﬁ  rst item of the Short 
Form-36 Health Survey and the Hospital Anxiety and Depression Scale. 
Functional disability was assessed using the Expanded Disability Status 
Scale. The probability of good self-rated health in employed persons was 
investigated using stepwise logistic regression analyses. MS patients who 
reported good self-rated health were 2.46 times more likely to be employed 
(95% conﬁ  dence interval [CI] 1.08-5.59). MS patients without anxiety were 
2.64 times more likely to be employed (95%CI 1.23-5.67). Patients with 
higher EDSS scores were 0.49 times less likely to be employed (95%CI 0.33-
0.70). Age, gender, disease duration and the presence of depression did 
not show an increased chance of patient employment. Patients with good 
self-rated health are more likely to be employed, even after adjusting for 
age, gender, education, functional disability, disease duration, depression 
and anxiety.
Introduction 
Self-rated health, a subjective assessment of health status, helps predict 
potential poor health outcomes, mainly in the elderly and in patients with 
chronic diseases. Several studies have shown the predictive effect of self-
rated health on mortality or survival time (1, 2). One large prospective 
study of healthy individuals showed that self-rated health may be an 
independent signiﬁ  cant predictor for the development of coronary heart 
disease (3).
Multiple Sclerosis (MS) is a chronic disease with an unpredictable 
course characterized by recurrent periods of inﬂ  ammation in the central 
nervous system, which are followed by diffused changes in the white 
and grey matter, the breakdown of myelin and damage to axons (4, 5). 
It is the most common cause of neurological disability in young adults. 
Symptoms begin between the ages 20 and 50 years in 90% of cases, and 
the disease strikes individuals during the peak years of their education, 
career development and family life, signiﬁ  cantly impacting their ability 
to remain in the workforce (4, 6). A study by Nortvedt et al (2000) 
investigated self-rated health as a predictive factor for the development 
of MS. The progression of the disease in an MS patient, as measured by 
the Expanded Disability Status Scale, can be assessed using self-rated 
health determined by one question from the SF-36 and by evaluating the 43
change in disability at the baseline measured by EDSS one year later. Since 
self-rated health is a subjective measure of disease activity, it provides 
important additional information apart from MRI, EDSS and the relapse 
rate of clinical course (7). 
Measures of functional disability, disease duration and clinical course 
all reﬂ  ect health status. A higher level of functional disability and longer 
disease duration have negative consequences on the health of MS patients 
(8, 9). Among the commonly described symptoms of MS measured in our 
study were a depressed mood and a feeling of anxiety. MS patients may 
develop depression as an understandable reaction to learning that they 
suffer from a chronic disease and will have to live with its consequences 
(10, 11). Anxiety, along with a high level of distress, occurs mostly in the 
ﬁ  rst years of diagnosis (12). 
Chronic diseases have an enormous impact on the ability to work 
(13). The relationship between health and employment status has been 
described in a considerable number of studies, and self-rated health 
appears to be strongly related to employment status in patients with 
lower back pain, coronary heart disease and HIV (13-17). A different 
characterization of job loss due to chronic diseases can be found in the 
literature. “Unemployment status” and “non-employment status” may 
have two different meanings. Unemployed people are those who are not 
active in paid work, but who are looking for jobs and are available for 
work (18, 19). In contrast, non-employed people are those who are jobless 
and have the intention to work, but who are unable to work because of 
serious impairments or disabilities (18, 19). 
Numerous factors may be considered when determining the ability 
to work among individuals with MS. The physical and cognitive functional 
limitations associated with MS are presumably the primary determinants 
of employment status in MS patients (20). With each point of increase in the 
functional disability score, the probability of being employed decreased 
by 7% when controlling for a large number of sociodemographic variables 
(21). Disease progression varies between disease courses in ways that 
could inﬂ  uence employment. Although there is a signiﬁ  cant overlap of 
symptoms between the current clinical courses, the ability to work may 
vary considerably between them. Study participants with the relapsing-
remitting course were found to have a higher frequency of employment 
than those having the primary-progressive course. An increased degree 
of disability is typical among individuals with the progressive course of 
MS (14, 20, 22).
Despite numerous studies on the ability of MS patients to work, it 
is still not clear whether self-rated health, as the ﬁ  rst question in the SF-
36 measure, is associated with employment status in MS patients. The 
direct relationship between disease variables and employment status are 
well known in MS (23). A similar question can then arise: Does self-rated 44 CHAPTER  3
health play an important role in relationship to employment status? The 
aim of this study was to explore the association between self-rated health 
and employment status in MS patients when controlling for age, gender, 
functional status, disease duration and psychological well-being. We 
hypothesized that MS patients with good self-rated health are more likely 
to be employed when controlling for age, gender, functional disability, 
disease duration, depression and anxiety.
Methods 
Study population
The sample consisted of MS patients from the eastern part of Slovakia. 
Data were collected from the winter of 2003 to the winter of 2006. MS 
patients from neurological outpatient clinics and members of MS clubs 
were included in the study. Patients underwent an interview and a physical 
examination. They completed several self-reported questionnaires on 
a voluntary and anonymous basis focusing on sociodemographic data, 
family life, health-related behaviour and disease history. 
The procedure started by sending the questionnaires, invitation 
letters and a written informed consent form to the participants’ homes by 
postal mail. After two weeks, a trained interviewer interviewed the MS 
patients personally in a neurologic outpatient clinic. A single neurologist 
then carried out a physical examination of all the patients. One additional 
call was made to those patients who did not come in order to arrange 
another examination. Exclusion criteria included: cognitive impairment 
determined by a Mini-Mental State Examination (MMSE) score of <24 
(24); a history of psychiatric or medical conditions affecting the outcomes 
of the study; pregnancy; non-Slovak speaking patients. 
The local Ethics Committee approved the study before its start. Each 
patient provided a signed informed consent form to participate in this 
study. 
Measures
Age, gender, marital status (living alone/single or married/cohabiting), 
education (elementary, secondary and university) and employment status 
were the variables ascertained from the self-reported questionnaire. 
Employment status was divided into four groups: 1) employed: full time 
or part-time, 2) non-employed: not employed or disabled due to MS, 
3) unemployed for other reasons than MS, and 4) a group consisting of 
students, housewives, those on maternity leave and retired persons. The 
study focused on the ﬁ  rst two groups.45
Self-rated health was measured using the Short Form-36 Health 
Survey (SF-36), which was originally designed as a generic indicator 
of health status for use in population surveys. The SF-36 includes eight 
multi-item scales used to measure the following eight dimensions: 
physical functioning, role limitation due to physical health, bodily pain, 
social functioning, general mental health (covering psychological distress 
and well-being), role limitations due to emotional problems, vitality and 
general health perceptions. In addition, one question covers the change 
in health status over the past year. The reason for only reporting the ﬁ  rst 
item instead of a broader description of perceived health status in MS 
patients is that self-rated health has been widely used in health studies 
as an indicator of general health status because it is generally accepted 
as a good predictor of mortality and morbidity. Self-rated health was 
assessed on a 5-point scale from 1 (excellent) to 5 (bad). The score was 
dichotomised into “good health” (excellent, very good, and good) and 
“fair health” (fair and bad health) (25, 26). 
Psychological well-being in MS patients was assessed using the 
Hospital Anxiety and Depression Scale (HADS) (27). The scale consists 
of 14 items, 7 of which are related to depression and 7 to anxiety. Patients 
responded on a 4-point scale (0=absent and 3=deﬁ  nitely  present/
severe). The scores ranged from 0 to 21, with a higher score implying that 
depression or anxiety is present to a larger extent. The score identiﬁ  es 
non-cases (a score of 7 or smaller), doubtful cases (a score of 8-10), and 
deﬁ  nitive cases (a score of 11 and higher) (27, 28). Cronbach’s alpha was 
0.79 for depression and 0.80 for anxiety in this study. 
The duration of MS, its clinical course (relapsing-remitting, 
secondary-progressive and primary-progressive) and functional disability 
(EDSS) were the MS variables obtained by the same neurologist. The 
Kurtzke Expanded Disability Status Scale (EDSS) is the most frequently-
used measure of disability in MS patients, with disability categories 
ranging from 1 (least severe) to 10 (most severe) (29). 
Statistical Analyses
Firstly, the sociodemographic variables, clinical variables (EDSS, disease 
duration, and clinical course), psychological well-being and self-rated 
health were described. Next, subgroups of MS patients with good and fair 
self-rated health were compared in sociodemographic variables, clinical 
variables and psychological well-being using an independent t-test. Finally, 
stepwise logistic regression analyses were used to examine the relative 
effect of self-rated health on employment status in MS patients when 
adjusting for age, gender, EDSS, disease duration and psychological well-
being. Age, gender, self-rated health, EDSS, disease duration, depression 
and anxiety were independent variables, while employment status was 46 CHAPTER  3
the dependent variable in these analyses. The results are reported as odds 
ratios, with 95% conﬁ  dence intervals (95% CI). 
Data were analysed using the Statistical Package for the Social 
Sciences, v.14.0 (SPSS; SPSS Inc., Chicago, Illinois, USA). 
Results 
At ﬁ   rst, the study included 223 questionnaires, which represents a 
response rate of 52.0%. Older MS patients in the study sample were 
slightly underrepresented, and non-respondents (45.1±10.5 years) 
were signiﬁ  cantly older than the participants (40.5±9.7 years) (p<0.05). 
However, there were no statistically signiﬁ  cant differences between non-
respondents and participants regarding gender. 
Data for 39 MS patients were not included in the analyses because 
the patients were unemployed for reasons other than MS (n=16), were full-
time students (n=13), were housewives or women on maternity leave (n=6) 
or were on a retirement pension (n=4). The activities of these groups differ 
from the activities we evaluated as being employed, or non-employed due 
to MS. The study group therefore consisted of 184 MS patients (33.7% 
male, 66.3% female) who were employed (patients working full-time or 
part-time due to MS) or non-employed (not employed and disabled due 
to MS). 
A basic description of the sample is given in Table 1 (n=184). The MS 
respondents averaged 40.5±9.7 years old and consisted of more women 
than men (66.3% female). Of all the participants, 35.9% were employed 
(29.6% full time), 46.6% were not employed and disabled due to MS, and 
17.5% belonged to the excluded groups. The mean EDSS score was 3.2±1.4, 
with a mean disease duration of 6.4±5.2 years. The majority of the patients 
belonged to the relapsing-remitting clinical course (68.0%). Of the sample 
of MS patients, 78.1% (score ≤7) reported no depression, 48.6% (score 
≤7) reported no anxiety, and the mean score for fair self-rated health was 
3.8±0.9 (Table 1). 47
Table 1 Description of the sample (n=184)
Variables N (%)  M SD Range
Age (years) 184 40.5 9.7 18 – 61
Gender 
Male 62 (33.7%)
Female 122 (66.3%)
Marital status
Living alone/single 31.5%
Married/cohabiting 68.5%
Education
Elementary 27.2%
Secondary 52.5%
University 20.3%
Employment status (n=223)
Full-time employed 29.6%
Part-time employed 6.3%
Student 5.8%
Housewives/maternity 2.7%
Unemployed 7.2%
Retired 1.8%
Disabled 46.6%
EDSS 3.2 1.4 1.0 – 8.5
Disease duration (years) 6.4 5.2 0.5 – 37.0
Clinical course
Relapsing-remitting 68.0%
Secondary-progressive 14.9%
Primary-progressive 17.1%
Depression 4.5 3.5 0 – 18
Not depressed ≤7 78.1%
Depressed >7 21.9%
Anxiety  7.8 2.8 2 – 16
Not anxious ≤7 48.6%
Anxious >7 51.4%
Self-rated health 3.8 0.9 1 – 5
Good 35.2%  1 – 3*
Fair  64.8%  4 – 5**
Note:
*Good health, 1-excellent, 2-very good, 3-good; **Fair health, 4-fair, 5-bad
EDSS, Expanded Disability Status Scale48 CHAPTER  3
Table 2 presents the differences in subgroups of MS patients deﬁ  ned 
by employment status with the use of an independent samples t-test, where 
continuous variables were independent variables. Younger MS patients 
(p<0.001), with lower EDSS scores (p<0.001), shorter disease duration 
(p<0.001), less depression (p<0.002) and less anxiety (p<0.004) were 
employed compared to non-employed MS patients. Elementary education 
was signiﬁ   cantly associated with non-employment of MS patients 
(p<0.001), while university education was associated with employment of 
MS patients (p<0.001). Better self-rated health was reported by employed 
patients than by non-employed MS patients (p<0.001) (Table 2). 
Table 2 Means and standard deviations of age, clinical variables, depression, anxiety and self-rated health 
differences, and numbers and percentages of sociodemographic variables by employed and non-employed 
MS patients (n=184)
Variables
Employment status
p – valuea
95% CIb Employed* 
Means (±SD) or N (%)
Non-employed** 
Means (±SD) or N (%)
Age  37.8 (±8.84) 42.6 (±9.75) 0.001
Gender (%)
Male  25 (31.2%)  37 (35.6%) -9.4 – 18.0%
Female   55 (68.8%)  67 (64.4%)
Marital status (%)
Married/cohabitating  51 (63.8%)  75 (72.1%) -22.0 – 5.3%
Living alone/single  29 (36.2%)  29 (27.9%)
Education (%)
Elementary  8 (10.8%)  40 (38.8%) -39.8 – 16.2%
Secondary  38 (51.4%)  55 (53.4%) -17.0 – 12.9%
University  28 (37.8%)  8 (7.8%) 17.9 – 42.3%
EDSS 2.4 (±1.07) 3.8 (±1.35) 0.001
Disease duration (in years) 4.6 (±4.07) 7.8 (±5.65) 0.001
Depression 3.6 (±3.14) 5.2 (±3.70) 0.002
Anxiety 7.2 (±2.80) 8.4 (±2.65) 0.004
Self-rated health 1.4 (± 0.50) 1.8 (±0.38) 0.001
Note:
EDSS, Expanded Disability Status Scale; Self-rated health, 1(excellent) to 5(bad)
a  For testing significant differences between subgroups of employed and non-employed MS patients the 
independent sample t-test was used where means for each variable are displayed; significant differences 
are in bold
b  Difference of proportions test (30); significant differences are in bold
* Employed, full-time or part-time employed MS patiens; **Non-employed, not employed or disabled due to 
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Logistic regression analyses were used to examine the probability 
of good self-rated health in the employment status of MS patients. The 
outcomes of the stepwise logistic regression models indicated that good 
self-rated health was more likely to be related to employment status when 
adjusted for age, gender, EDSS, disease duration, depression, and anxiety. 
The results are presented in Table 3.
MS patients who reported good self-rated health had a 2.46 times 
greater chance of being employed (95% conﬁ  dence interval [CI] 1.08-5.59), 
while patients with higher EDSS scores were less likely to be employed. 
The odds ratio (OR) of EDSS for employment status was 0.49 (95%CI 
0.33-0.70). MS patients without anxiety had a 2.64 times greater chance 
of being employed (95%CI 1.23-5.67). The results of logistic regression 
analyses did not show that age, gender, disease duration, nor the presence 
of depression, increase a patient’s chance of being employed (Table 3). 
Table 3 The effect of self-rated health on employment status when adjusted for age, gender, functional 
disability, disease duration, depression and anxiety (the final table of the stepwise logistic regression) 
Variables B Odds ratio 95% CI p-value
Age -0.001 1.00 0.96-1.04 0.962
Gender
Male -0.12 0.89 0.40-1.97 0.766
Female 1
Self-rated health
Good health* 0.900 2.46 1.08-5.59 0.031
Fair health** 1
EDSS -0.724 0.49 0.33-0.70 0.001
Disease duration -0.076 0.93 0.84-1.02 0.112
Depression
Depressed 1
Not depressed 0.618 1.85 0.73-4.69 0.192
Anxiety
Anxious 1
Not anxious 0.972 2.64 1.23-5.67 0.012
Note:
Results were significant at: *p<.05; **p<.01; ***p<.001
Significant p-values are in bold
*Good health, 1-excellent, 2-very good, 3-good; **Fair health, 4-fair, 5-bad
EDSS, Expanded Disability Status Scale 
CI, confidence intervals; B, unstandardized coefficient50 CHAPTER  3
Discussion 
MS is accompanied by important physical, psychological and social 
consequences. The present study explores the relationships between self-
rated health and employment status according to age, clinical variables 
and psychological well-being in MS patients. 
The results provide support for the hypothesis that good self-rated 
health was signiﬁ  cantly associated with employment status in the MS 
patients surveyed. The correlation coefﬁ  cients between the main variables 
showed that low age, university education, low functional disability, short 
disease duration, no anxiety, no depression and good self-rated health 
were all related to employment status in MS patients. MS patients with 
good self-rated health were more likely to be employed than those who 
assessed their self-rated health as fair. In this sample, MS patients showed 
the desire to be employed, but they were not able to work because of 
the worsened disability caused by MS. Disorders of strength, sensation, 
coordination and balance, as well as visual, cognitive and effective deﬁ  cits 
may lead to severe progressive limitations of functioning in daily life, 
employment status included (31). Our results are in line with the study 
by Rietberg et al, which showed that MS patients cannot work when they 
report poor self-rated health (31). 
Although logistic regression analyses showed less signiﬁ  cant 
associations between good self-rated health and employment status 
when adjusted for functional disability and disease duration, self-rated 
health still remains a signiﬁ  cant indicator for being employed. The results 
are consistent with studies in which good health was associated with 
employment status in MS patients (9, 14, 32). 
Following the results, self-rated health showed to be a variable more 
strongly associated with employment status than functional disability. 
Functional disability caused by MS is measured on a continuum of 0 (normal 
neurologic examination) to 10 (death due to MS) according to Kurtzke’s 
EDSS score (29). It is reﬂ  ected in individual physical symptoms, which 
may vary from patient to patient, and can be compared with outcomes 
of perceived health status as measured using the SF-36 questionnaire. 
The SF-36, with its physical and mental summary components, appears 
to be an appropriate means of measuring the progression of disease and 
functional abilities in MS patients and can be easily used by healthcare 
professionals. 
The effect of a low level of depression on employment status was 
weak and was not found to be signiﬁ  cant in our study. The absence of 
anxiety was associated with being employed. The risk factor of major 
anxiety on low work capability could be demonstrated with its negative 
impact on work, social and family concerns in MS patients (33). Well-51
intentioned family members and employers advise people with MS to 
leave employment as a way of dealing with the issues of fatigue, pain 
and stress. Considering the consequences of premature retirement and 
reduced participation in general, with respect to ﬁ  nancial security, the 
social network, health status and psychological well-being, it may be far 
more beneﬁ  cial to assist MS patients who wish to continue employment 
by following up with coping strategies than to advise them to leave 
employment (34). 
Since this study is based on cross-sectional data, it cannot be 
determined with certainty whether poor self-rated health is the reason for 
the inability to work. Therefore, the role of self-rated health as a predictor 
of employment status in a longitudinal study may be noteworthy and 
warrant discussion. As several studies have shown a predictive effect of 
self-rated health on mortality or survival time in chronic diseases (1, 2), it 
would be worth assessing the role of good self-rated health in predicting 
the future working ability in MS patients in a longitudinal study. This 
seems to be useful not only for the patients themselves, but also for 
their entire families in terms of economic status. Data gathered from MS 
patients, as well as family members and employers, could provide a great 
deal of information about the types of work accommodations that are 
useful and effective for employment status. MS patients with progressive 
clinical courses may not be able to work when poor health, low functional 
status and the presence of depression and anxiety could affect work 
and family life (20, 35). On the contrary, employment status may be a 
major factor for social support because of its social network supporting 
adaptation to physical illness. Positive social interaction is associated with 
better health (36). 
The participating MS patients were signiﬁ  cantly younger than the 
non-respondents, which can be considered as a limitation of this study. 
We may assume that a smaller proportion of the oldest group, probably 
the group with the longest disease duration, or the most affected group, 
did not participate. One possible consequence of this might be that 
outcomes regarding employment status are more related to younger MS 
patients than to older ones, and that the results cannot be extended and 
generalized to the whole MS population. MS patients in the study sample 
were signiﬁ  cantly more likely to be working than older patients. We may 
assume then that older MS patients in the MS population have fewer 
chances to be employed than younger MS patients. 
Regarding future research, other factors not analysed in this study, 
such as fatigue or cognitive dysfunctions, might also contribute to non-
employment in MS patients. Performing subgroup analyses in an attempt 
to determine factors other than clinical variables or depression and 
anxiety that could contribute to non-employment in MS patients would 
be helpful. Furthermore, outcomes concerning the summary scales of the 52 CHAPTER  3
SF-36, like the summary physical and summary mental scales, or even on 
a more detailed level the dimensions of the SF-36, such as role physical, 
role emotional, general mental health, etc., would be interesting to study. 
Scores ranging from 0 to 100 will be available that should provide the 
basis for further analysis. 
In conclusion, this study supports to some extent existing evidence 
of the beneﬁ  cial impact of good health on work ability in patients with 
MS. Our results showed that MS patients with good self-rated health 
are more likely to be employed, even after adjusting for age, gender, 
education, functional disability, disease duration, depression and anxiety. 
Taking these ﬁ  ndings into account, self-rated health may be used as a 
quick and cheap prognostic marker which can warn about the possible 
loss of employment, or changes in functional disability. However, these 
results should be proven in a study that is longitudinal in design. MS 
patients without anxiety may have increased chances for working. It 
can be assumed that not only does the employment rate decline with 
worsening health related to the progression of disease, but that the 
network of supportive people from work needed for coping decreases as 
well, although this was not subject of our study. The importance of good 
health and maintaining employment status for patients suffering from MS 
could be therefore mutual.
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Abstract 
Objective: The main aim of this study was to investigate whether different 
levels of perceived social support are associated with different levels of 
perceived health status in multiple sclerosis (MS) patients.
Methods:  Two hundred and seven MS patients (38.4±10.6 years, 66.2% 
female) completed the Short Form-36 Health Survey (SF-36) as the 
measure for perceived health status, and the Perceived Social Support 
Scale (PSSS) as the measure for social support. Functional disability was 
assessed using Kurtzke’s Expanded Disability Status Scale (EDSS). The 
contribution of EDSS and PSSS for explaining the variance in SF-36 was 
investigated with multiple linear regression analysis. 
Results: Demographic variables and EDSS explained 44% of the variance 
of the physical health summary scale in the SF-36. Demographic variables, 
EDSS and PSSS from family and friends explained 24% of the variance in 
mental health summary scale in the SF-36. Results varied according to the 
multiple linear regression analyses of predictors of variance in the eight 
dimensions of the SF-36. 
Conclusion: PSSS from signiﬁ  cant others was positively associated with 
general health dimension of perceived physical health status, while PSSS 
from family and friends was positively associated with perceived mental 
health status in MS patients. 
Practice Implications: The results show the importance of supporting social 
ties and relationships between MS patients and others. 
Introduction
Multiple sclerosis (MS) is a chronic autoimmune disease with an uncertain 
course, with symptoms beginning between ages 20 and 50 years in 90% 
of the cases. It is the most common cause of neurological disability in 
young adults (1, 2). The socio-medical model of the disablement process 
explains how chronic and acute conditions affect functioning in speciﬁ  c 
body systems, physical and mental activities, and activities of daily life in 
young adults with MS.
Personal and environmental factors can speed up or slow down the 
disablement of patients. Patients become limited not only in employment 
but also educational opportunities, or interpersonal relationships as well 
(3-5). Functional disability has been associated with restricted social 
participation. The disease usually starts during the ﬁ  rst two decades 59
of employment in a patient’s life. Several studies have investigated the 
relationship between functional disability and perceived health status in 
MS patients (6-9). 
Social support includes the supportive input which different people 
receive from their social environment, and almost any type of social 
interaction may be considered as social support (10, 11). It is assumed that 
social support has two important types of functions: the health-sustaining 
function has a direct effect on the well-being of individuals. Social support 
contributes to the positive adjustment and development of personality. 
On the other hand, social support also has an indirect stress-reducing or 
buffering function (12-14).
Generally, social support is supposed to inﬂ   uence three basic 
levels: emotional (love and affection), instrumental (helping hands) 
and informational (providing information). The ﬁ  nal component is the 
perception of social resources that refer to the subjective evaluation of 
the level of quality of the support (10, 15). Emotional and informational 
supports can strengthen the perception that the stressor is not as bad 
as originally believed. Emotional support is helpful no matter who the 
source is. Emotional support is helpful when it comes from family and 
friends or when it comes from healthcare professionals (10). However, 
patients usually prefer informational support more from the physicians 
and nurses than from family (10). 
Social support has been the most frequently studied psychosocial 
resource. Structural aspects of social support usually refer to the functions 
performed for the individual by three groups: family, friends and 
signiﬁ  cant others (16, 17). The group ‘signiﬁ  cant others’ includes persons 
who are relevant for the patients, in this case for instance co-workers, 
health care professionals or other MS patients (18); that is to say, relevant 
persons besides ‘family (including partner)’, and ‘friends’. The authors 
of the scale of Perceived Social Support presented the importance of 
exploring speciﬁ  cally whom subjects consider as constitutive of ‘special 
person’ in the signiﬁ  cant others subscale. The meaning of signiﬁ  cant 
others can be dependent on the patient’s age, marital status, social and 
cultural conditions when interviewed. Signiﬁ  cant others could be taken to 
refer to a number of different individuals. Clariﬁ  cation of this issue would 
be necessary (16). Apart from these, important sources of informational 
support could be peer groups or psychotherapeutic groups led by experts 
(10). Subjects who are employed or studying can feel positive relationships 
from signiﬁ  cant others like colleagues, fellow students and teachers who 
can provide them social support. When they participate in a work team 
or study group, they can feel positive relationships with signiﬁ  cant others 
like fellow students, teachers or co-workers who can provide them social 
support. Koopman et al (19) identiﬁ  ed the needs of individuals with MS. 60 CHAPTER  4
The main aim of this study is to investigate whether different levels of 
perceived social support are associated with different levels of perceived 
health status in MS patients. We expected that:
1. Social support provided by family, friends and signiﬁ  cant others is 
positively associated with perceived physical and mental health status 
in MS patients independently from basic demographic variables and 
functional disability.
2. Social support provided by family, friends and signiﬁ  cant others is 
positively associated with the separate dimensions of perceived physical 
and mental health status in MS patients independently from basic 
demographic variables and functional disability.
Methods
Participants and sample size 
The sample consisted of 207 MS patients from neurology outpatient clinics 
and members of MS societes in the eastern part of Slovakia; they were 
included in the study between December 2003 and July 2006. Exclusion 
criteria were as follows: cognitive impairment determined by a Mini-
Mental State Examination (MMSE) score of <24 (20); history of psychiatric 
or medical conditions affecting the outcomes of the study; pregnancy; non 
Slovak speaking patients; under 18 years of age.
Of the 412 MS patients who were deemed eligible for the study, 207 
patients were interviewed (50.2%) and 205 MS patients did not respond. 
The 205 non-responders consisted of 180 patients from outpatient clinics 
(87.8%), 20 patients from hospitals (9.8%) and 5 non-responders from 
MS societies (2.4%). There were no statistically signiﬁ  cant differences 
between the non-responders and the participants regarding gender, 
disease duration and clinical course of MS. However, the non-responders 
(45.1±10.5 years) were signiﬁ  cantly older than the participants (38.4±10.6 
years) (p≤.05). 
Description of sample 
The sample consisted of 66.2% women and 33.8% men with a mean age of 
38.4±10.6 years (range 18-65 years). The mean disease duration measured 
as time from diagnosis was 5.3 years (range 0.5-15.5). Almost three quarters 
of the sample had the relapsing-remitting course of MS (72.2%). The mean 
EDSS score was 3.0±1.5 (Table 1). Interferon beta therapy in Slovak MS 
patients was accessible only for MS patients aged 45 years or less, mostly 
suffering from relapsing-remitting or secondary-progressive clinical 
courses. Fifty six per cent of the included MS patients in this study were 
treated with Interferon beta therapy. Some patients were limited in using 61
ambulatory devices (30.1%). A smaller group always required assistance 
always in all daily activities or mechanical devices were necessary (16.9%) 
and some of them were wheel-chair bound (4.4%).
MS patients in this group mostly lived with a partner (63.8%). Mostly 
younger MS patients in this sample were never married (30.9%), lived 
in their own apartment or house (63.4%), and had secondary education 
(54%). They were currently employed (31.2%). Non-employed were 
retired due to MS (49.8%), unemployed (8.8%), or had other duties (daily 
students, those on retirement pension, housewives, women on maternity 
leave; 10.2%) (Table 1). 
Table 2 shows the description of perceived social support and the 
social networks. MS patients reported small social networks, which 
consisted of their partner, extended family and friends. MS patients were 
asked questions which thoroughly described their social network: “How 
often do you come into general contact with your relatives (personal 
meeting, phone calls, writing letters, email contacts; the members of 
household were not meant)? How often do you get into general contact 
with friends and acquaintances? How often do you go to a club or pub?” 
At the end of the interview MS patients were asked: “Could you state, that 
you are hindered by your physical and mental health in maintaining your 
contacts with other people?” (Table 2).62 CHAPTER  4
Table 1 Description of the sample (n=207)
Variable % M SD Range
Age  38.4 10.6 18 – 65
Gender 
Male 33.8
Female 66.2
Marital status
Married/cohabiting 63.8
Living alone/single 36.2
Education 
Elementary 29.0
Secondary 54.0
University 17.0
Employment status
Employed 31.2
Non-employed 68.8
Clinical course
Relapsing-remitting 72.2
Secondary-progressive 10.7
Primary-progressive 17.1
Disease duration 5.3 4.1 0.5 – 15.5
EDSS 3.0 1.5  1.0 – 8.5
Treatment 
Disease-modifying drugs  56.0
Other 44.0
Type of assistance
Ambulatory devices 30.1
Permanent required assistance  16.9
Wheel-chair bound  4.4
SF-36
Physical health summary scale 48.5 20.2 10 – 100
Mental health summary scale 57.0 16.2 13 – 96
Note:
Higher scores indicate more disability (EDSS), more social support (PSSS) and better functioning (SF-36);
EDSS-Expanded Disability Status Scale; PSSS-Perceived Social Support Scale; SF-36-Short Form-36 
Health Survey63
Table 2 Perceived social support and social networks in the sample (n=207)
Variable % M SD Range
PSSS 
Family  23.0 4.9 4 – 28
Friends  20.7 5.1 4 – 28
Others  23.2 4.9 4 – 28
Social network
Contact with relatives
Never  1.4
Once per month  8.7
2-3 times per month 20.3
Once per week 21.3
2 or more times per week 42.0
Contact with friends
Never  1.0
Once per month  9.7
2-3 times per month 20.3
Once per week 22.7
2 or more times per week 39.6
Going to club/pub
Never 24.6
Once per month 15.0
2-3 times per month 10.2
Once per week  7.7
2 or more times per week  5.3
Hindered by health problems in 
maintaining contacts 
Not at all 61.3
Little 23.7
Fairly   9.7
Very much  4.8
Note:
PSSS-Perceived Social Support Scale64 CHAPTER  4
Procedure
This cross-sectional study consisted of several self-reported 
questionnaires, a semi-structured interview and a physical examination. 
The questionnaires, invitation letters and written informed consent were 
sent to the participants’ homes by postal mail. After two weeks a trained 
interviewer interviewed the MS patients in the neurology outpatient clinic. 
A neurologist carried out a physical examination. The questionnaires 
focused on socio-demographic variables like age, gender, partnership, 
education, employment status and social network.
The local Ethics Committee approved the study before it started. 
Each patient provided a signed informed consent to participate in this 
study. 
Measures 
Functional disability
The most frequently used measure of disability in MS patients is the 
Kurtzke Expanded Disability Status Scale (EDSS) (21). It is based upon 
neurological testing of functional systems: pyramidal, cerebellar, 
brainstem, sensory, bowel and bladder, visual, mental and ‘other’. Each 
functional system is graded to the nearest possible grade, 0 means normal 
grade, 6 means loss of function and V indicates an unknown abnormality. 
Disability caused by MS grades on continuum of 0 (normal neurological 
examination) to 10 (death caused by MS) (21). 
Self-perceived health status
The Short Form-36 Health Survey (SF-36) was originally used as a generic 
indicator of health status for use in population surveys and evaluative 
studies of health policy (22). The SF-36 includes eight multi-item scales 
to measure these eight dimensions: 1. physical functioning (ten items), 
2. role limitation due to physical health (four items), 3. bodily pain (two 
items), 4. social functioning (two items), 5. general mental health (ﬁ  ve 
items), 6. covering psychological distress and well-being (ﬁ  ve items), 7. 
role limitations due to emotional problems (three items), 8. vitality, energy 
or fatigue (four items). In addition, one question covers change in health 
status over the past year (one item) and the study also focuses on general 
health perceptions (ﬁ  ve items). We used the physical health summary 
scale (perceived physical health status, dimensions 1-4) and the mental 
health summary scale (perceived mental health status, dimensions 5-8). 
All item scores are coded and transformed into a scale of 0 (poor health) 
to 100 (optimal health) (22, 23). Cronbach`s alpha for the SF-36 total score 
in the present sample was 0.93; for the physical health summary scale 
0.89 and for the mental health summary scale 0.89. The physical health 65
summary scale mean score was 48.5±20.2 and the mental health summary 
scale mean score from SF-36 was 57.0±16.2 (Table 1). 
Perceived social support
The 12–item perceived social support scale was used for measuring the 
perceived availability and satisfaction with social support. The scale 
yields three subscale scores for Family, Friends and Signiﬁ  cant others, and 
a total score. Using a 7-point Likert scale, the items should be scored from 
1 (very strongly disagree) to 7 (very strongly agree). After this, the value 
of the items was counted together for each of the three dimensions. A high 
score means a high level of perceived social support (16, 24). Cronbach`s 
alpha for the total score in the perceived social support scale was 0.93; for 
social support provided by family members 0.91, by friends 0.93 and by 
signiﬁ  cant others 0.89, indicating very satisfactory reliability. The mean 
score for perceived social support scale from family was 23.0±4.9, from 
friends 20.7±5.1 and from others 23.2±4.9 (Table 1).
Statistical analyses
The relationships between demographic variables, functional disability, 
perceived health status and social support were examined using Pearson 
correlations. The relative contributions of social support controlled for 
demographic variables and functional disability towards explaining the 
variance in physical and mental health summary scales in MS patients 
were investigated with multiple linear regression analysis. In these 
analyses the SF-36 summary scales were dependent variables, whereas 
age (measured in years), gender, education (categorized into elementary, 
secondary and university), marital status (categorized into married/
cohabiting and living alone/single), employment status (categorized into 
employed and non-employed), functional disability and perceived social 
support were independent variables. 
Data were analysed using the Statistical Package for the Social 
Sciences, v.12.0.1 (SPSS). 
Results
Correlations between the study variables
The correlation coefﬁ  cients between the variables showed the signiﬁ  cant 
relationships. Age (r=-.44, p≤.01), elementary education (r=-.23, p≤.01) 
and EDSS (r=-.53, p≤.01) were negatively associated with the physical 
health summary scale. Living alone/single (r=.20, p≤.01), employed 
(r=.36, p≤.01), social support from family (r=.17, p≤.05) and social 
support from signiﬁ  cant others (r=.18, p≤.01) were signiﬁ  cantly positively 66 CHAPTER  4
associated with the physical health summary scale. Age (r=-.26, p≤.01), 
elementary education (r=-.16, p≤.05) and EDSS (r=-.27, p≤.01) were 
negatively associated with the mental health summary scale. Living alone 
(r=.19, p≤.01), employed (r=.36, p≤.01), social support from family (r=.34, 
p≤.01), social support from friends (r=.31, p≤.01) and social support from 
signiﬁ  cant others (r=.30, p≤.01) were positively signiﬁ  cantly associated 
with the mental health summary scale in MS patients. EDSS, clinical 
course and disease duration were not signiﬁ  cantly associated with the 
dimensions of perceived social support in MS patients.
Multiple linear regression analyses 
With physical and mental health summary scales as dependent variables, 
multiple linear regression analyses were used to examine the contribution 
of independent variables to these scales (Table 3). 
Dependent variables included physical and mental health status, 
while independent variables consisted of demographic data, functional 
disability and social support. Higher age, being unemployed and higher 
EDSS were negatively associated with a low score in the physical health 
summary scale. Higher age and worse EDSS were signiﬁ  cantly negatively 
associated with a lower score in the mental health summary scale. Better 
social support from family and friends was positively associated with a 
higher score in the mental health summary scale in MS patients.
Multiple linear regression analyses in physical health summary scale SF-36
Demographic variables, EDSS and social support explained 44% of the 
variance in the physical health summary scale. Results varied according 
to the predictors of variance in the single dimensions of SF-36. Social 
support from signiﬁ  cant others signiﬁ  cantly explained the variance in 
general health in the physical health summary scale (β=.22, p≤.05) (Table 
3). Age, elementary education and EDSS were signiﬁ  cant predictors of the 
single dimensions in the SF-36. 
Multiple linear regression analyses in mental health summary scale SF-36
Demographic variables, EDSS and social support from family and friends 
signiﬁ  cantly explained 24% of the variance in the mental health summary 
scale. Social support provided by family and friends explained more of the 
variance in the mental health summary scale than in the physical health 
summary scale of SF-36 (β=.19 and β=.18, p≤.05) (Table 3). Regarding the 
single dimensions in the SF-36, social support from family signiﬁ  cantly 
explained the variance in social functioning and role-emotional (β=.23, 
p≤.05; β=.26, p≤.05; respectively). Social support from friends explained 
the variance in the vitality and mental health dimensions (β=.17, 
p≤.05; β=.20, p≤.05 respectively). Age was a signiﬁ  cant predictor of six 
dimensions, male gender was the signiﬁ  cant predictor of one dimension 67
and EDSS was found to be the signiﬁ  cant predictor of ﬁ  ve dimensions of 
the SF-36 (Table 3).68 CHAPTER  4
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Discussion and conclusion
Discussion
The main aim of the study was to investigate whether MS patients with 
different levels of perceived social support report different levels of 
perceived health status. Our results provide evidence for the hypothesis 
that social support given by family, friends and signiﬁ  cant others may 
be positively associated with perceived health status. Social support 
provided by family and friends was positively associated with ﬁ  ve out of 
eight single dimensions of perceived health status in MS patients. 
Social support and perceived physical health status 
Social support explained no variance in the physical health summary 
scale in MS patients. Results showed that age and functional disability 
were much stronger predictors than perceived social support in the single 
dimensions of the physical health summary scale. Social support from 
signiﬁ  cant others contributed to the single dimension, a general health, in 
the physical health summary scale. 
The participants in this study were in regular contact with the MS 
outpatient clinic, with its neurologist and nurse. Signiﬁ  cant others like 
healthcare professionals can be an important resource of social support. 
They provide information, knowledge and encouragement (19, 25). 
Moreover, MS patients rely on the help of neurologists in a conﬁ  dential 
relationship. The feeling of conﬁ  dence in patients can signiﬁ  cantly reduce 
the effects of stress experiences on their physical and psychological 
outcomes (26, 27). 
Patients with the same diagnosis can help each other and can 
support the health status using exchanged information and tips for 
coping with disability due to MS. They tend to meet each other in MS 
societies around the whole country. Thoits (18, 28) underlined that the 
most effective support-givers were similar others. They are the patients 
who have successfully faced the same stressful circumstances that other 
MS patients are currently facing (18, 28). 
Other studies have consistently shown that social support may be a 
major factor in adaptation to physical illness and positive social interaction 
is associated with better physical functioning (26, 29-32). 
Social support and perceived mental health status 
The expectation that positive social support from family and from friends 
would explain the mental health summary scale variance was conﬁ  rmed. 
The more social support from family MS patients perceived, the better 
their assessments were of their social and emotional functioning. The 70 CHAPTER  4
more social support from friends MS patients reported, the higher 
their assessments were of their vitality and better mental health in the 
dimensions of the SF-36. No single dimension of perceived health status 
was explained by social support from signiﬁ  cant others.
The explanation may be that MS patients, who look for support 
from family and friends, report the feeling as being strengthened and 
encouraged more than when they look for social support from signiﬁ  cant 
others. The results of this study are in line with ﬁ  ndings that more social 
support contributes to better mental health status. Willingness to talk 
openly about MS on the part of spouses leads towards positive coping 
(25, 33). 
Families who talk about MS do better at living with MS. The more 
patients reach out for help when they need it, the better. It is vital as a 
protection against isolation that family and friends understand the patients 
with MS. The sense that patients belong to others promotes positive well-
being. Social support enhances patients’ psychological well-being directly 
by fulﬁ  lling their need for belonging, and thus counteracting feelings of 
loneliness (33, 34). 
The most important predictors of physical health status seem to be 
age, elementary education and functional disability, while mental health 
status is associated also with social support. It appears that there is a little 
change in the contribution of social support with regard to the dimensions 
of physical health status. For the dimensions of mental health status, the 
contribution of social support was more visible. Our results are in line 
with previous studies (18, 25) which consider social support mainly as a 
psychosocial and not as a physical construct. 
It has been pointed out that different types of social support are 
necessary for different dimensions of health in MS patients. The partner 
relationship is generally thought to be one of the most important resources 
of social support, because the partner is the main provider of emotional 
and instrumental support (34). Similarly, the effects of perceived social 
support have been most frequently examined, especially the effects of 
perceived emotional support (beliefs that love and caring, sympathy and 
understanding, esteem and value are available from family members) (18).
Because the data in this study are cross-sectional, the observed results 
merely reﬂ  ect associations, and issues of causality cannot be adequately 
addressed. Speculating about the ﬁ  ndings in a more causal way might 
imply that more perceived social support could have a positive inﬂ  uence 
on perceived physical and mental health status in MS patients. Each health 
dimension in the SF-36 could be inﬂ  uenced by a different type of social 
support and could have an additive effect on particular perceived health 
values in MS patients. The inspection of bivariate correlations between the 
study variables did not conﬁ  rm signiﬁ  cant associations between functional 
disability, disease duration, or clinical course of MS on the one hand and 71
social support dimensions on the other hand. In addition, the possible 
interaction effect of functional disability and social support was analysed 
using multiple regression analysis. The interactions were computed for 
functional disability and each dimension of social support separately, but 
no signiﬁ  cant interactions were revealed. There is still a need to examine 
the role of perceived social support in a prospective design to better assess 
the buffering effects of perceived social support on physical and mental 
health status in MS patients. 
This study has primarily focused on the positive consequences of 
social support in MS patients and interactions with other people. The 
consequences of social support may not necessarily be positive. MS 
patients may experience negative aspects from the social environment. 
Negative interactions are salient and unexpected, so they can have a 
stronger impact on the perceived health status in MS patients (35). 
There is a growing body of literature about the importance of 
psychosocial recourses in the disablement process. The studies highlight 
the inﬂ  uence of social support in promoting individuals’ well-being under 
the conditions of disability (36, 37). On the other hand, there is still a lack 
of studies about the effect of social support provided by family, friends and 
signiﬁ  cant others on health status in MS patients in the literature (25). 
Participating MS patients were signiﬁ  cantly younger than the non-
responders. We may assume that non-responders were a proportion of the 
oldest MS group with the longest disease duration, and possibly the most 
affected group, which might have prevented them from the participating. 
The possible consequence might be that outcomes are more related to the 
younger MS patients than to the older ones, and that the results cannot be 
extended and generalized to the whole MS population.
Conclusion
This study demonstrates that social support provided by signiﬁ  cant 
others is positively associated with general health dimension of perceived 
physical health status measured with SF-36, while social support 
provided by family and friends was found to have a positive relationship 
with perceived mental health status in MS patients. Furthermore, the 
more social support from family MS patients perceived, the better their 
assessments were of their social and emotional functioning in the SF-36 
dimensions. The more social support from friends MS patients reported, 
the better their assessments were of their higher vitality and better mental 
health in the single dimensions of the SF-36. The study revealed that social 
support provided by family and friends was mainly related to perceived 
mental health status. A different basis of social support is necessary for 
different dimensions of perceived health status in MS patients.72 CHAPTER  4
Practice implications 
The study shows that social support is associated with perceived health 
status in MS patients. Strengthening recommendations for social support 
is connected with effective coping with MS. A good family background 
and network of friends is most important for the mental health status. If 
social support is lacking, supplying effective prevention and intervention 
programmes by healthcare professionals as signiﬁ  cant others could be 
helpful. Group therapy would be appropriate for expressing and sharing 
problems of MS patients lacking social support. MS patients could thus 
participate in programmes focusing on developing self-management 
skills and providing social support (38). 
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Abstract 
Background: Multiple sclerosis (MS) is a chronic disease that is difﬁ  cult to 
predict and to cope with. Mastery refers to the extent to which patients 
see themselves as being in control of the forces that affect their lives. It 
may play an important role in perceived health status and well-being. The 
purpose of this study was to clarify whether mastery is associated with 
functional disability and perceived health status in MS patients and how 
such an association might function. 
Methods: Two hundred and three MS patients completed the Short Form-
36 Health Survey as well as the Pearlin-Schooler Mastery Scale. Functional 
disability was assessed using the Kurtzke Expanded Disability Status 
Scale. Hierarchical multiple linear regression analyses were performed on 
the data from two MS age groups: <45 and ≥45 years of age.
Results: Functional disability was negatively associated with perceived 
physical health status in both age groups and with perceived mental 
health status in younger age group. Mastery was positively associated 
with perceived health status in older age group. 
Discussion: The ﬁ  ndings conﬁ  rm that mastery might be helpful for older 
MS patients. Education strategies for MS patients aimed at personal 
empowerment for the maintaining of physical and mental well-being may 
be important.
Introduction
Multiple sclerosis (MS) is a chronic disease that follows an unpredictable 
course as it affects the central nervous system. It is the most common 
cause of neurological disability in young adults, with the incidence of 
symptoms appearing and varying over time (1, 2). Functional disability 
has been associated with restricted participation in employment, 
educational opportunities, interpersonal relationships and leisure-time 
activities for MS patients (3-5). A socio-medical model of the disablement 
process explains how chronic and acute conditions affect the functioning 
of speciﬁ  c bodily systems, physical and mental activities and the activities 
of daily life. Personal and environmental factors can speed up or slow 
down the disablement of patients (6, 7).
Disablement status has been found to be reﬂ  ected in the perceived 
health status of the chronically ill (6, 7), and several studies have also 
investigated this relationship in patients with MS. With the progression 79
of a disability, it is primarily physical functioning that shows a decrease in 
perceived health status. As previous studies have reported, a higher level 
of functional disability has negative consequences on perceived health 
status in MS patients (5, 8, 9). Quantifying the clinical impact of MS on 
perceived health status can be assessed in clinical trials and in everyday 
practice in order to optimize individual patient care (10-12). 
Mastery as a part of a patient’s self-concept could be useful in 
achieving better health status. Mastery refers to the extent to which people 
see themselves as being in control of the forces that signiﬁ  cantly affect 
their lives. It is considered as responsive to the conditions of people’s lives 
(13). Mastery is studied from the perspective of ways of coping with a 
progressing chronic disease (14, 15). The positive effect of higher mastery 
on physical and mental health in disabled elderly persons has been shown 
in many studies (16-18). Low mastery has been identiﬁ  ed as a risk factor 
for functional decline in older people in The Netherlands (19). Mastery, or 
perceived control in elderly persons, is crucial for maintaining functional 
ability in later life. It makes a unique contribution to changes in functional 
disability (19, 20). 
Lower levels of mastery are associated with greater depression. 
Mastery shows a signiﬁ   cant interaction with functional disability in 
predicting depression, and it has a protective role with regard to mental 
health in older people. Similarly, mastery and perceived health status 
of senior adults with orthopaedic disabilities have been studied, with 
mastery correlating positively with positive health perceptions and 
relating inversely to depression. Higher levels of mastery buffer against 
the anxiety associated with greater impairment in physically disabled 
adults as well (16, 17, 21). 
There is inconsistency in the ﬁ  ndings about the associations between 
age and mastery. Increasing mastery with increasing age may reﬂ  ect the 
attainment of personal and institutional resources that contribute to greater 
mastery (17, 22). However, there are also studies that report decreasing 
mastery with increasing age (16, 17, 22, 23). Functional disability is seen 
as being more related to mastery for older people because it occurs in the 
context of other negative changes. Some studies have found the inﬂ  uence 
of disability on mastery to be affected by age, and their interaction differs 
across age groups (14, 23, 24). Older and younger MS patients may differ 
in coping strategies in their lifetime, therefore there is an assumption that 
they differ in self-concept, including mastery.
Within the context of this study age is an important factor that might 
play a role in the perception of health, disability and mastery. To improve 
functioning or just to stop the decrease in functional disability, different 
therapeutic strategies are used in MS patients. New disease-modifying 
drugs are the most commonly used approach (25). In Slovakia, these 
disease-modifying drugs are accessible predominantly for MS patients 80 CHAPTER  5
aged 45 year or younger, suffering mainly from relapsing-remitting or 
secondary-progressive clinical courses (26).
The study was conducted because, thus far, little research has been 
done with MS patients regarding the associations between mastery, 
functional disability and perceived health status. Younger MS patients 
(<45 years of age) might differ in the evaluation of mastery and their 
health status when compared to older MS patients (≥45 years of age). 
The aim of this study was to clarify whether mastery is associated with 
functional disability and perceived health status in MS patients and 
how such an association might function. We expected better mastery 
and less functional disability to be associated with higher perceived 
physical and mental health status in MS patients even when controlled 
for relevant sociodemographic and clinical variables. We also expected 
that the relationship between mastery and functional disability, with its 
associations to perceived physical and mental health status, would differ 
between younger and older age groups of MS patients. 
Methods
Patients 
The sample consisted of MS patients from the eastern part of Slovakia. 
Data were collected from December 2003 to January 2006. MS patients 
from neurology outpatient clinics and members of MS clubs were 
included in the study. Outpatient clinics were addressed and MS patients 
were recruited from those who were eligible to participate. Firstly, 
questionnaires, invitation letters and written informed-consent forms 
were sent to the participants’ homes by postal mail. After two weeks, 
a trained interviewer spoke with the MS patients personally in the 
neurological outpatient clinic. A neurologist then carried out neurological 
examinations immediately after the interview. These examinations were 
done by the same neurologist for all patients. One phone call to arrange 
one more interview was made to those who did not come.
Out of 405 adult MS patients addressed, 214 patients responded 
and returned the questionnaires (a crude response rate of 52.8%). From 
these, 11 patients were excluded because of low MMSE or other exclusion 
criteria. Finally, 203 were included in the study (for an effective response 
rate of 50.1%; males 35.7%, females 64.3%). There were no differences 
between the non-responders and the participants regarding gender. 
A signiﬁ  cant difference was found in age (p<0.05); the non-responders 
(mean age 45.1±10.5 years) were signiﬁ  cantly older than the participants 
(mean age 38.3±10.6 years).81
During the interview, patients completed several self-reporting 
questionnaires and went through physical examinations on a voluntary 
and anonymous basis. Sociodemographic data, including gender, age, 
marital status, living situation, education level, employment status, family 
life and disease history were derived from the interview. Mastery and 
perceived health status were obtained from the questionnaires. Clinical 
data, including functional disability, disease duration and clinical course, 
were assessed by the neurologist, who was the same for all outpatient 
clinics. The duration of MS was assessed during the interview and 
neurological examinations by the same neurologist and compared with 
data in the patient’s medical ﬁ  le. The framework of formal procedure of 
translation and adaptation of questionnaires to the Slovak language was 
respected. Questionnaires were translated from English into Slovak, and 
then the Slovak version was translated back into English and compared 
with the original version. Measures were tested in a pilot study with 10 MS 
patients. Exclusion criteria were as follows: non-Slovak-speaking patients, 
cognitive impairment determined by a Mini-Mental State Examination 
(MMSE) score of <24 (27), history of psychiatric or medical conditions 
affecting the outcomes of the study, and pregnancy. In MS pregnancy 
has been a matter of controversy for a long time. Pregnancy can modify 
the clinical course of disease with a reduced relapse rate, or on the other 
hand, can cause an increased relapse rate after delivery (28, 29). Symptoms 
like pain, fatigue, anxiety or less participation in daily activities may 
occur during pregnancy and are similarly described in MS patients. The 
responses may thus misrepresent perceived health status and may change 
the study outcomes in women with MS. 
Ethics
Each patient provided a signed informed-consent form before participation 
in the study. The local Ethical Committee approved the study. 
Measures
The Kurtzke Expanded Disability Status Scale (EDSS) is based on 
the neurological testing of functional systems: pyramidal, cerebellar, 
brainstem, sensory, bowel and bladder, visual, mental and “other” (30). 
Each functional system is graded to the nearest possible grade, where 
0 means normal grade, 6 means loss of function and “V” indicates an 
unknown abnormality. Disability caused by MS is graded on a continuum 
from 0 (normal neurological examination) to 10 (death caused by MS) 
(30). This measure, with its widespread use, remains the most frequently-
used scoring system in MS in neurological practice (25). It belongs in the 
category of physician-oriented measures, as information is based on an 82 CHAPTER  5
objective neurological examination, which in this study was performed by 
the same neurologist on all respondents. 
The Short Form-36 Health Survey (SF-36) was originally designed 
as a generic indicator of health status for use in population surveys 
and evaluative studies of health policy (31). The SF-36 consists of eight 
dimensions which can be summarized into two health summary scales to 
measure those eight dimensions. The ﬁ  rst, the physical health summary 
scale, contains four dimensions: 1. physical functioning (ten items), 2. role 
– physical (four items), 3. bodily pain (two items) and 4. general health 
(ﬁ  ve items). The second, the mental health summary scale, also contains 
four dimensions: 5. vitality (four items), 6. social functioning (two items), 7. 
role – emotional (three items) and 8. mental health (ﬁ  ve items). In addition, 
one question covers changes in health status over the past year (one item), 
and the study also includes general health perceptions (ﬁ  ve items). All 
item scores are coded and transformed into a scale from 0 (poor health) 
to 100 (optimal health). Higher scores on the physical and mental health 
summary scales indicate better functioning (31, 32). Cronbach‘s alpha for 
the total score in the present research was 0.93; for the physical health 
summary scale it was 0.89 and for the mental health summary scale 0.89.
The Pearlin-Schooler Mastery Scale (PMS) measures the global sense 
of personal control (33). It consists of seven items in which high scores 
represent a strong sense of mastery. Patients responded on a 5-point 
Likert scale about the extent to which they agreed (5=strongly agree) or 
disagreed (1=strongly disagree) with statements such as “I can do just 
about anything I really set my mind to” and “I often feel helpless in 
dealing with the problems of life.” A PMS score ranges from 7 to 35, with 
higher score reﬂ  ecting greater mastery. The PMS was applied to a sample 
of MS patients providing information about its validity (r=0.73) (34). In 
the present study, Cronbach´s alpha for this measure was 0.75.
Statistical analyses 
To examine the relationships between mastery, functional disability and 
perceived health status the following steps were taken. Firstly, mean scores, 
standard deviations and ranges of scores were calculated for all variables. 
Next, Pearson’s correlations were used for testing the associations amongst 
socio-demographic factors, disease duration, functional disability, disease 
course, perceived physical and mental health status and mastery. Third, 
hierarchical multiple regression analyses with the ‘enter method’ were 
performed in order to identify how much of the variance of the dependent 
variable (SF-36) may be explained by sociodemographic factors, functional 
disability and mastery. The block of sociodemographic variables (age, 
education, gender, marital status, employment) were entered into the 
equation at Step 1; functional disability (as measured by the EDSS) was 83
entered at Step 2 and ﬁ  nally, mastery was entered into the equation at 
Step 3 in the total sample (Table 3). In the groups of younger (<45) and 
older (≥45) MS patients functional disability (as measured by the EDSS) 
was entered at Step 1 and mastery was entered into the equation at Step 2 
separately (results presented in Table 4). Hierarchical multiple regression 
analyses were performed for the total sample (results presented in Table 
3) as well as for samples of younger (<45) and older (≥45) MS patients 
(results presented in Table 4). The age cut-off of 45 years was based on 
accessibility to disease-modifying drugs in this sample (26, 35). 
Data were analyzed using the Statistical Package for the Social 
Sciences 12.0 (SPSS Inc., Chicago, IL, USA).
Results
Basic description of the sample
A basic description of the sample is given in Table 1 (n=203). In general, the 
MS responders were of middle age (mean age 38.3±10.6 years), consisted 
of more women than men (64.3% females), were married or cohabiting 
(64.1%), had secondary education (51.7%) and were not employed 
(65.5%). 
Almost three quarters of the sample had the relapsing-remitting 
course (72.3%). The average duration of disease, measured as time from 
diagnosis, was 5.3±4.1 years (range 0.5-15.5). The mean EDSS score was 
3.0±1.5. The physical health summary scale mean score was 48.6±20.2, and 
the mental health summary scale mean score of SF-36 came to 57.0±16.1. 
The mean score for mastery was 21.5±5.5 (Table 1).
The subgroup of the younger MS patients (<45 years old; mean age 
32.6±6.9 years; 69.0% female) had predominantly the relapsing-remitting 
course (82.7%) with a mean duration of illness of 4.7±3.7 years. The 
subgroup of older MS patients (≥45 years old; mean age 50.8±4.9 years; 
53.1% female) had the relapsing-remitting course in 48.4% and the mean 
duration of illness was 6.8±4.4 years. The main study variables with 
means and standard deviations for the two age groups of MS patients are 
described in Table 1.84 CHAPTER  5
Table 1 Description of the study sample and two age groups of MS patients: <45 years of age and ≥45 
years of age 
Total sample
(n=203)
<45 age group 
(n=139)
≥45 age group 
(n=64)
Variable n (%) or mean±SD n (%) or mean±SD n (%) or mean±SD
Gender 
Women 130 (64.3) 96 (69.0) 34 (53.1)
Age  38.3±10.6 32.6±6.9 50.8±4.9
Marital status
Living alone/single 73 (35.9) 61 (43.9) 12 (18.8)
Married/cohabiting 130 (64.1) 78 (56.1) 52 (81.2)
Living situation
Own apartment/house 126 (62.1) 49 (35.3) 45 (70.3)
Education
 Elementary  58 (28.6) 38 (27.3) 20 (31.3)
Secondary 105 (51.7) 75 (53.9) 30 (46.9)
University  33 (16.3) 26 (18.7) 7 (10.9)
Employment status
Employed/studying 69 (40.0) 53 (38.1) 16 (25.0)
Not employed 133 (65.5) 86 (61.9) 47 (73.4)
Disease duration 5.3±4.1 4.7±3.7 6.8±4.4
EDSS 3.0±1.5 2.7±1.5 3.7±1.3
Clinical course
Relapsing-remitting 146 (72.3) 115 (82.7) 31 (48.4)
Secondary-progressive  21 (10.3) 6 (4.3) 15 (23.4)
Primary-progressive 35 (17.2) 17 (12.2) 18 (28.1)
SF-36
Physicala 48.6±20.2 53.4±19.9 37.6±16.4
Mentala 57.0±16.1 58.7±16.6 53.1±14.2
Mastery 21.5±5.5 21.2±5.6 22.0 ±5.3
Note:
EDSS, Expanded Disability Status Scale; SF-36, Short Form-36 Health Survey
aHigher scores indicate ‘better functioning’
Correlations between study variables
Table 2 demonstrates the signiﬁ  cant cross-sectional relationships between 
variables. EDSS and clinical course are strongly positively correlated with 
disease duration; EDSS is strongly negatively correlated with physical and 
mental health status in MS patients. Disease duration and clinical course 
are negatively associated with the physical summary scale. Regarding the 
mental summary scale, clinical course is negatively correlated with this 
scale, while mastery positively correlates with it. Mastery appeared not to 85
be associated with the main variables of interest, EDSS and the physical 
health summary scale in the total sample (Table 2). When comparing the 
correlations in younger and older MS patients, mastery was signiﬁ  cantly 
associated with EDSS (r=-0.33; p≤0.01), clinical course (r=-0.34; p≤0.01), 
physical summary scale (r=0.39; p≤0.01) and mental summary scale 
(r=0.33; p≤0.01) only in the older MS age group. Signiﬁ  cant relationships 
between EDSS and the physical health summary scale in the SF-36 were 
found (Table 2; r=-0.53; p≤0.01).
Table 2 Pearson’s correlations between the studied variables 
1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11.
1. Age -
2. Education ns -
3. Gender ns ns -
4. Marital status -.42** ns ns -
5. Employment .14* .42** ns ns -
6. Disease duration .29** ns ns ns .20** -
7. EDSS .33** -.21** -.15* ns .31** .36** -
8. Clinical course .35** ns ns ns .19** .32** .63** -
9. Physical SF-36 -.43** .24** ns .19** -.35** -.23** -.53** -.38** -
10. Mental SF-36 -.25** .18* ns .19* -.21** ns -.30** -.27** .64** -
11. Mastery ns ns ns ns ns ns ns ns ns .18* -
Note:
*p<.05; **p<.01
Marital status 1=married/cohabiting, 2=living alone/single; Employment 1=employed/studying, 2=not 
employed; Gender 1=men, 2=women; ns=no significance; for abbreviations see Table 1
Physical health status 
In the whole group of MS patients, 41.6% of the variance in perceived 
physical health status was explained by a model consisting of age, gender, 
marital status, education, employment, EDSS and mastery (p≤0.001). 
EDSS was the strongest variable associated with perceived physical health 
status in these patients (ß=-0.34; p≤0.001) (Table 3). 
Table 4 presents the explained variance of the model consisting of 
EDSS and mastery in the age groups <45 years and ≥45 years. The larger 
variance of perceived physical health status was explained in the age group 
≥45 years (adjusted R2=0.24; p≤0.01). EDSS was signiﬁ  cantly associated 
with perceived physical health status in both age groups. Mastery was 
signiﬁ  cantly associated with perceived physical health status in older MS 
patients (≥45 years old), but not in younger ones (<45 years old) (ß=0.31, 
p≤0.01; ß=0.01, not signiﬁ  cant; respectively). 86 CHAPTER  5
Mental health status
With regard to perceived mental health status, 14.6% (p≤0.001) of the 
variance was explained by a model consisting of age, gender, marital 
status, education, employment, EDSS and mastery in the total sample 
(Table 3). 
Table 4 presents the results of the analyses for two age groups. The 
examined model consisting of EDSS and mastery explained the largest 
variance in perceived mental health status in the group of MS patients 
≥45 years (adjusted R2=0.12, p≤0.01). EDSS appeared to be signiﬁ  cant 
variable related to perceived mental health status in younger MS patients 
(<45 years old), but not in older ones (≥45 year old) (ß=-0.19, p≤0.05; 
ß=-0.19, not signiﬁ  cant). In contrast, in the group of older MS patients, 
mastery was signiﬁ  cantly associated with perceived mental health status 
(ß=0.28; p≤0.05) (Table 4). 
Table 3 Hierarchical multiple regression analysis: sociodemographic variables, EDSS and mastery on 
perceived physical and mental health status 
Physical health status 
SF-36
Mental health status 
SF-36
Adjusted R2 ß Adjusted R2 ß
1st step Age -.33*** -.25**
Education   .11 .06
Gender   -.06  -.10
Marital status  .03 .06
Employment  32.0  .14* 12.7 .14
2nd step EDSS 41.9  -.34*** 13.5 -.08
3rd step Mastery 41.6  .01 14.6 .13
Note:
*p<.05; **p<.01; ***p<.001 
Adjusted R2 are displayed; significant values are displayed in bold; for abbreviations see Table 187
Table 4 Hierarchical multiple regression analyses: EDSS and mastery on perceived physical and mental 
health status in younger (<45) and older (≥45) MS patients
Age groups
Physical health 
status SF-36
<45 ≥45
R2 ß R2 ß
1st step EDSS .22*** -.48*** .17** -.43**
2nd step EDSS
Mastery
.22*** -.48***
 .01
.24** -.34**
 .31**
Mental health 
status SF-36
<45 ≥45
R2 ß R2 ß
1st step EDSS .03* -.19*  .06*  -.27*
2nd step EDSS
Mastery
.04* -.19*
.15
 .12**  -.19
 .28*
Note:
*p<.05; **p<.01; ***p<.001
EDSS, Expanded Disability Status Scale; adjusted R2 values and ß values are displayed; significant values 
are displayed in bold
Discussion 
This study aimed at examining the association between mastery, functional 
disability and perceived health status in MS patients. Better mastery 
and less functional disability were expected to be associated with better 
perceived physical and mental health status. 
The results provide support for the hypothesis that the negative 
association between functional disability  and perceived health status 
was signiﬁ  cant. This ﬁ  nding is in line with existing studies on functional 
disability and perceived health status (6, 11, 36). Our results also show that 
better mastery is associated with a higher perceived physical health status 
and perceived mental health status. These results are in line with previous 
ﬁ  ndings in other chronically disabled patients, where mastery predicts 
rising levels of psychological well-being and quality of life among these 
people (15, 37). 
Although mastery was not correlated with the variables of interest 
when examining the sample as a whole, when looking at the speciﬁ  c 
age groups, mastery was associated with perceived health status for the 
older participants but not for the younger ones. Multiple linear regression 
analyses performed separately for the two age groups clearly showed that 
mastery explained more variance in the perceived physical and mental 
health status in older MS patients than in younger ones. Similarly, in a 
study by Forbes, mastery was signiﬁ  cantly related to health status and 
perceived health in a group of elderly community-dwelling people (18). 88 CHAPTER  5
For the younger age group functional disability appeared to be the most 
important variable for explaining variances in the physical health status 
of MS patients. 
The SF-36 as a generic indicator allows for the comparison of the health 
status of chronic patients with different conditions and can be related to 
the prognosis of disease and intervention outcomes (31, 38). The outcomes 
of the perceived physical and mental health summary scales in the present 
study are comparable to the ﬁ  ndings of other European studies focusing 
on health status in MS patients. Perceived health status in MS patients 
inevitably worsens due to MS, and thus the scores in the dimensions of 
perceived physical and mental health status are low (3, 5, 10).
The ﬁ  ndings show that functional disability is positively associated 
with the age of MS patients. This is a consequence of MS being a 
progressive chronic disease, although a direct association between 
functional disability and mastery was not conﬁ  rmed. To summarize the 
results, worse functional disability, higher mastery and worse perceived 
health status in the older age group than in the younger one could suggest 
that the progress of MS should be taken into account. Patients may adapt 
to the conditions of their lives with MS, and older MS patients perhaps 
know better what to expect and how to behave in response to possible 
deterioration of their health status. They may undergo a psychological 
adjustment process enabling them to cope with impairment (39). This 
adjustment is important for coping with the disease, for the feeling of 
having control of one’s life.
Our ﬁ  ndings  conﬁ   rm that mastery might be helpful for older 
persons with MS. Individuals with greater mastery are more likely to 
use preventive care, have good health behaviours, seek treatment early 
and use health services properly (17, 40, 41). Patients with a strong self-
concept (high self-esteem and mastery) may be more likely to “see the 
light at the end of the tunnel” and consequently predict positive outcomes 
for themselves despite their current problems (42). 
Some limitations should be noted in the generalisation of our 
results. MS patients participating in this study were signiﬁ  cantly younger 
than the non-responders. We may assume that the non-responders were a 
proportion of the oldest MS group, with the longest disease duration and 
possibly the most affected group, which might have prevented them from 
participating. The results cannot be therefore extended and generalized to 
the whole MS population, as the oldest group of MS patients was missing 
from this study. Also, the existence of unique features of the national health 
care system may lead to a certain limitation of this study. In particular 
the inaccessibility to disease-modifying drugs in MS patients over age 45 
may lead to differences when outcomes are compared with patients from 
other countries. In addition, the outcomes of this cross-sectional study 
cannot be causally determined. Mastery and its stability is a subject of 89
controversy. In order to clarify stability or changes in mastery over time 
in MS patients, a longitudinal study design is needed. Longitudinal data 
are needed to further unravel the complex interplay between functional 
disability, perceived health status and mastery in MS patients. 
The clinical importance of this study is that older patients possessing 
higher levels of mastery have a greater likelihood of perceiving mental 
health status more positively than those who are less disabled but have 
lower mastery. This may be assumed to involve individuals’ mastery in 
making personal choices and deciding the level of participation in health 
care and society (22). In the end, their quality of life might be better. 
Clinical implications
The results of our analyses suggest that mastery can be a variable important 
for perceived mental health status, especially in MS patients aged 45 years 
and over. The consequences for clinical practice are aimed especially 
at the group of older MS patients who are less likely to experience a 
signiﬁ  cant improvement of their health status. On the other hand, these 
patients report more physical and psychological health complaints. 
Therefore, more intensive medical and psychological attention should 
be paid mainly to older MS patients. Education strategies for groups of 
MS patients, provided by psychologist or trained nurses and focused on 
personal empowerment for maintaining physical and mental well-being 
in the face of MS, may be important. A collaborative strategy during group 
psychotherapy may allow MS patients to share their knowledge regarding 
how to inﬂ  uence attitudes and to improve physical and mental health. 
MS patients may effectively mobilize personal resources better and cope 
with the disease and thus may perceive their mental health as better with 
a higher level of mastery. Hence, there is a challenge for future research 
to measure self-efﬁ  cacy and social support like other related variables 
associated with perceived health status in MS patients. Neurologists’ 
education and counseling supporting the coping strategies of MS patients 
are essential for good patient management. 
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Abstract 
Higher levels of depression and anxiety have a negative impact on the 
disease process in multiple sclerosis (MS) patients. The aim of this study 
was to explore whether there are the discrepancies in the association of 
depression and anxiety with perceived physical and mental health status, 
and whether these associations differ between younger and older MS 
patients. 
The study sample consisted of 223 MS patients who were divided 
into two age groups: those under 45 years (n=149) and those age 45 years 
or older (n=74). A model consisting of age, gender, marital status, EDSS, 
depression and anxiety explained 46.6% of the variance in perceived 
physical health status and 60.8% of the variance in perceived mental 
health status in the total sample. Depression was signiﬁ  cantly associated 
with perceived physical health status in both younger (p≤0.05) and 
older (p≤0.001) MS patients. Depression was also signiﬁ  cantly related 
to perceived mental health status in both age groups (p≤0.001). Anxiety, 
however, was signiﬁ  cantly associated with perceived physical and mental 
health status in the younger age group (p≤0.05; p≤0.001), but not in the 
older one. 
The role of depression is always present in MS patients with regard 
to their perceived health status, mainly to perceived physical health status 
in the older group and to perceived mental health status in the younger 
one. The role of anxiety is more important in younger MS patients than 
among older patients with regard to their perceived health status. 
Introduction
Multiple sclerosis (MS) is a chronic and unpredictable neurological 
disease that varies from a mild course with minimal disabilities to a 
rapidly progressing or ﬂ  uctuating course resulting in disabilities. No 
reliable indicators exist to assure patients that their status will remain 
stable or that disabilities will not arise or progress. Furthermore, patients 
are confronted with symptoms that frequently and unpredictably vary 
with respect to their form and intensity, sometimes even daily (1). 
Symptoms include sensory and motor loss, fatigue, difﬁ  culties with 
balance, ataxia, muscular weakness, pain, cognitive impairments and 
mood disorders. MS is the most common cause of neurological disability 
in young adults (2).
Disablement status has been found to be reﬂ  ected in the perceived 
health status of the chronically ill (3). With the progression of a disability, 
it is primarily physical functioning that shows a decrease in perceived 
health status in patients with MS. As previous studies have reported, 97
a higher level of functional disability has negative consequences on 
perceived health status in MS patients (4, 5). The clinical impact of MS 
on perceived health status can be quantiﬁ  ed and assessed in clinical trials 
and in everyday practice in order to optimize individual patient care (6, 
7). Many neurological scales associated with functional disability are used 
to measure perceived health status in MS patients (8). When MS patients 
are compared to controls, they score signiﬁ  cantly lower than the general 
population in disability measures (4, 8-10).
Depressed mood and anxiety are among the most commonly 
described symptoms of MS. MS patients may develop depression as 
an understandable reaction to their experiencing a chronic disease and 
having to live with its consequences (11, 12). Anxiety, along with a high 
level of distress, occurs mostly in the ﬁ  rst years of diagnosis (13). High 
levels of depression and anxiety were found to be negatively associated 
with physical and mental health status in chronically ill patients (14-16). 
The negative impact of depressive symptoms on perceived health status in 
MS patients has also been demonstrated (7). In some studies, depression 
seems to be associated with worse scores in self-reported questionnaires, 
independent of the clinical course or disability status of the MS patients 
(5, 17). Statistically, as many as 60% of patients with MS experience major 
depression, and the suicide rate among those with MS is 7.5 times higher 
than that of the age-matched general population (12). 
Perceived health status, measured using the SF-36 questionnaire, 
has been evaluated as an appropriate instrument for measuring general 
health. It assesses four physical health domains and four mental health 
domains, and MS patients show lower scores for both the physical health 
summary scale and for the mental health summary scale in the SF-36 than 
the general population (18). 
Within the context of this study, age is an important factor that 
might play a role in perceiving health, assessing functional disability 
and evaluating psychological well-being. Older age seems to be related 
to lower scores in perceived health status (7), though the association of 
depression and anxiety with age in MS patients is still unclear. Some 
studies have reported the prevalence of a greater risk of depression in 
younger MS patients. When younger and older MS patients are compared, 
the younger patients appeared to be more depressed than the older ones. 
Other studies have revealed a high rate of anxiety prevalence, with higher 
levels of anxiety at disease onset (19-21). 
This study was conducted because younger and older MS patients 
might differ in evaluating their psychological well-being and health status. 
The aim of this study was to explore whether there are discrepancies in 
the association of depression and anxiety with perceived physical and 
mental health status, and whether these associations differ in younger 
(<45 years) and older (≥45 years) MS patients. We expected depression 98 CHAPTER  6
and anxiety in MS patients to be signiﬁ  cantly associated with perceived 
physical and mental health status, even when controlled for the relevant 
sociodemographic and clinical variables. We also expected this relationship 
to differ between younger (<45 years) and older (≥45 years) MS patients. 
Methods
Patients and procedures
MS patients from neurology outpatient clinics and members of MS clubs 
were included in the study. Outpatient clinics were addressed and MS 
patients were recruited from those who were eligible to participate. The 
sample consisted of 223 MS patients from the eastern part of Slovakia. 
Data were collected from December 2003 to January 2006. Firstly, 
questionnaires, invitation letters and written informed-consent forms were 
sent to participants’ homes by post. After two weeks, a trained interviewer 
spoke with the MS patients personally in a neurological outpatient clinic. 
A neurologist then carried out a neurological examination immediately 
after each interview. These examinations were performed by the same 
neurologist for all patients. One phone call to again arrange an interview 
was made to those patients who did not come the ﬁ  rst time.
This cross-sectional study consisted of several self-reported 
questionnaires, a semi-structured interview and physical examinations 
on a voluntary and anonymous basis. Socio-demographic data, including 
age, gender, marital status, living situation, education level, employment 
status, family life and disease history, were ascertained from the 
interview. Depression, anxiety and perceived health status were obtained 
from the questionnaires. Clinical data, including functional disability, 
disease duration and clinical course, were assessed by the neurologist. 
Questionnaires were translated from English into Slovak, and then the 
Slovak version was translated back into English and compared with 
the original version. Measures were tested in a pilot study with 10 MS 
patients. Exclusion criteria were as follows: non-Slovak-speaking patients, 
cognitive impairment determined by a Mini-Mental State Examination 
(MMSE) score of <24 (22), a history of psychiatric or medical conditions 
affecting the outcomes of the study and pregnancy. 
Each patient provided a signed informed-consent form before 
participating in the study. The local Ethics Committee of the University 
Hospital approved the study on December 17th, 2002. 
Measures
The Kurtzke Expanded Disability Status Scale (EDSS) is based on 
the neurological testing of functional systems: pyramidal, cerebellar, 99
brainstem, sensory, bowel and bladder, visual, mental and “other”. 
Disability caused by MS is graded on a continuum from 0 (normal 
neurological examination) to 10 (death caused by MS) (23). This measure, 
with its widespread use, remains the most frequently used scoring system 
in MS in neurological practice. It belongs to the category of physician-
oriented measures, as information is based on an objective neurological 
examination, which in this study was performed by the same neurologist 
on all respondents (24). 
Psychological well-being was assessed with the Hospital Anxiety 
and Depression Scale (HADS) (25). The scale consists of 14 items, 7 of 
which are related to depression and 7 to anxiety. Patients respond on a 
4-point scale (0=absent and 3=deﬁ  nitely present/severe), and the score 
ranges from 0 to 21, with a higher score implying that depression or 
anxiety is present to a larger extent. The score identiﬁ  es non-cases (a score 
of 7 or smaller), doubtful cases (a score from 8-10) and deﬁ  nitive cases (a 
score of 11 or higher) (25). Cronbach’s alpha for depression was 0.79 and 
for anxiety 0.81 in this study. 
The Short Form-36 Health Survey (SF-36) was originally used as a 
generic indicator of health status in population surveys and evaluative 
studies of health policy (26). The SF-36 includes the measurement of the 
eight dimensions of health: 1. physical functioning (ten items), 2. role 
limitation due to physical health (four items), 3. bodily pain (two items), 
4. social functioning (two items), 5. general health (ﬁ  ve items), 6. mental 
health, covering psychological distress and well-being (ﬁ  ve items), 7. role 
limitations due to emotional problems (three items), and 8. vitality, energy 
or fatigue (four items). In addition, one question covers changes in health 
status over the past year (one item). We used the physical health summary 
scale (perceived physical health status) and the mental health summary 
scale (perceived mental health status). All item scores were coded and 
transformed into a scale of 0 (poor health) to 100 (optimal health) (26, 
27). Cronbach’s alpha for the SF-36 total score in the present sample was 
0.93; for the physical health summary scale it was 0.90, and for the mental 
health summary scale 0.89. 
To improve functioning or to simply stop the decrease in functional 
ability, different therapeutic strategies are used in MS patients (24). 
Disease-modifying drugs (DMD) are a commonly used approach, and 
in Slovakia DMD were, until recently, accessible predominantly for 
MS patients aged 45 year or younger suffering mainly from relapsing-
remitting or secondary-progressive clinical courses (28). This is the reason 
why we chose 45 years old as our cut-off point. All patients in our sample 
of <45 years used DMD’s. 
It is important to control for variables that can frequently inﬂ  uence 
study outcomes. Many studies in recent years have found associations 
between sociodemographic variables, functional disability and health 100 CHAPTER  6
status in patients with MS. Patients who were younger, were male, were 
engaged and who had low functional disability reported better perceived 
health status (4, 29-31). 
Statistical analysis
Firstly, the sociodemographic variables (age, gender, marital status), 
clinical variables (EDSS, disease duration, clinical course), psychological 
well-being (depression, anxiety) and perceived health status (physical and 
mental health summary scales) were described. Pearson’s correlations 
were used for testing the associations between the examined variables. 
The cut-off age of 45 years in this sample was based particularly on the 
prescription of DMD to MS patients. The Mann-Whitney U test was 
conducted to determine the differences in scores between younger (<45 
years) and older (≥45 years) age subgroups of MS in sociodemographic 
variables, clinical variables, psychological well-being and perceived health 
status. Finally, hierarchical multiple regression analyses were performed 
using the “enter method” in order to identify how much of the variance of 
dependent variables (physical and mental health summary scales) may be 
explained by age, gender, marital status, functional disability, depression 
and anxiety. Hierarchical multiple regression analyses were performed 
for the total sample, as well as for samples of younger (<45 years) and 
older (≥45 years) MS patients (ﬁ  nal results presented in Table 3). 
Data were analysed using the Statistical Package for the Social 
Sciences, v.16.0 (SPSS). 
Results
Basic description of the sample
In general, the respondents (n=223) were of middle age (mean age 
38.9±10.8 years), consisted of more women than men (67.3% females), 
were married or cohabiting (64.6%), had secondary education (54.6%) 
and were not employed (59.4%). The main study variables with means 
and standard deviations for the whole sample and for the two age groups 
of MS patients (<45 years and ≥45 years) are described in Table 1. The 
younger group signiﬁ   cantly differed statistically from the older age 
group in more often living alone/single, shorter disease duration, lower 
EDSS and a more frequent a relapsing-remitting course. Furthermore, 
the younger group had less depression, better perceived physical health 
status and better perceived mental health status (Table 1).
The 223 questionnaires represented a response rate of 52.0%. Non-
respondents (45.1±10.5 years) were signiﬁ  cantly older than the participants 
(38.9±10.8 years) (p<0.05), though there were no statistically signiﬁ  cant 101
differences between the non-respondents and the participants regarding 
gender.
Table 1 Description of the study sample and two age groups of MS patients: <45 years of age and ≥45 
years of age 
Variablesa
Total sample 
(n=223)
<45 age group 
(n=149)
≥45 age group 
(n=74)
n (%) or mean±SD n (%) or mean±SD n (%) or mean±SD
Age  38.9±10.8 32.7±6.9*** 51.2±4.9***
Gender 
Women 67.3% 69.8% 62.2%
Marital status
Living alone/single 35.4% 44.3%*** 17.6%***
Married/cohabiting 64.6% 55.7% 82.4%
Disease duration 5.8±5.2 4.9±4.4*** 7.6±6.3***
EDSS 3.1±1.5 2.7±1.5*** 3.7±1.3***
Clinical course
Relapsing-remitting 70.9% 83.7%*** 45.2%***
Secondary-progressive 13.2% 4.8% 30.1%
Primary-progressive 15.9% 11.6% 24.7%
HADS
Depression 4.5±3.6 4.2±3.5* 5.3±3.8*
Anxiety 7.1±4.2 6.8±4.2 7.6±4.2
SF-36
Physical Summaryb 48.1±20.4 53.0±20.1*** 37.7±16.7***
Mental Summaryb 56.7±16.0 58.6±16.6** 53.0±14.0**
Note: 
*p<.05; **p<.01; ***p<.001
aThe significance test on the differences between subgroups of younger and older MS patiens was 
on the Mann-Whitney U test on continuous variables; bhigher scores indicate “better functioning”; 
EDSS=Expanded Disability Status Scale; HADS=Hospital Anxiety and Depression Scale; SF-36=Short 
Form-36 Health Survey
Correlations between study variables
Table 2 demonstrates the signiﬁ  cant cross-sectional relationships between 
the variables used in this study. Marital status (married/cohabiting) is 
signiﬁ  cantly correlated with better physical and mental health status in 
MS patients. Age, disease duration, EDSS, clinical course, depression and 
anxiety are strongly associated negatively with the physical summary 
scale. Age, EDSS, clinical course, depression and anxiety are strongly 
associated negatively with the mental summary scale. 102 CHAPTER  6
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Perceived physical health status
Table 3 shows that 46.6% of the variance of perceived physical health status 
in the whole group of MS patients was explained by a model consisting of 
age, gender, marital status, EDSS, depression and anxiety. EDSS appeared 
to be the strongest variable associated with perceived physical health 
status in the total sample (ß =-0.44, p≤0.001) (Table 3). 
The variance in perceived physical health status explained in both 
age groups was very similar: 39.8% in the younger group and 38.8% in 
the older group of MS patients. Discrepancies were found with regard to 
the importance of EDSS and anxiety in the younger group (<45 years) and 
of depression in the older (≥45 years). EDSS was the strongest variable 
associated with perceived physical health status in the younger age 
group (<45 years) (ß=-0.47, p≤0.001), while depression was the stronger 
variable related to perceived physical health status in the older age group 
(≥45 years) (ß=-0.39, p≤0.001). Anxiety was signiﬁ  cantly  associated 
statistically, albeit weakly, with perceived physical health status in the 
younger age group (<45 years) (ß=-0.16, p≤0.05), but not in the older one 
(≥45 year) (ß=-0.17, not signiﬁ  cant) (Table 3).
Perceived mental health status
In the total sample of MS patients, 60.8% of the variance in perceived 
mental health status was explained by a model consisting of age, gender, 
marital status, EDSS, depression and anxiety. Anxiety appeared to be the 
strongest variable associated with perceived mental health status in the 
sample of all MS patients (ß=-0.32, p≤0.001) (Table 3).
In younger MS patients (<45 years), 65.0% of the variance in 
perceived mental health status was explained by a model consisting of 
age, gender, marital status, EDSS, depression and anxiety, while the same 
model explained 47.2% of the variance in perceived mental health status 
in older MS patients (≥45 years). Depression appeared to be the strongest 
variable associated with perceived mental health status in both age groups 
(ß=-0.49, p≤0.001; ß=-0.47, p≤0.001 respectively), with higher explained 
variance in younger MS patients (<45 years). Anxiety was signiﬁ  cantly 
associated with perceived mental health status in the younger age 
group (<45 years) (ß=-0.37, p≤0.001), but not in the older one (≥45 years) 
(ß=-0.20, not signiﬁ  cant) (Table 3). 104 CHAPTER  6
Table 3 Final results from the hierarchical multiple regression analyses: sociodemographic variables, 
EDSS, depression and anxiety on perceived physical and mental health status in the total sample, and in 
younger (<45) and older (≥45) MS patients
Total sample Age groups
Physical health 
status SF-36
<45 ≥45
Adjusted R2 ß Adjusted R2 ß Adjusted R2 ß
Age 16.7%  -.19*** 6.0%  -.20** 0.3% .07
Gender 0.0% -.03 0.0% -.07 0.0% -.03
Marital status 0.0% .05 0.0% -.02 3.6%  .17
EDSS 19.0%  -.44*** 24.2%  -.47*** 13.7%  -.38***
Depression  3.6%  -.24*** 2.3% -.20* 10.3%  -.39***
Anxiety 7.3% -.15* 7.3% -.16* 10.9% -.17
 Adjusted R2 46.6% 39.8% 38.8%
Mental health 
status SF-36
<45 ≥45
Adjusted R2 ß Adjusted R2 ß Adjusted R2 ß
Age 6.4% -.05 3.9% -.09 3.7% -.02
Gender 0.6% -.03 0.0% .00 4.0% -.15
Marital status 0.0% .04 0.0% .02 3.3% .11
EDSS 4.3%  -.16*** 3.0% -.13* 4.1% -.21*
Depression  16.4%  -.50*** 42.6%  -.49*** 16.0%  -.47***
Anxiety 33.1%  -.32*** 15.5%  -.37*** 16.1% -.20
 Adjusted R2 60.8% 65.0% 47.2%
Note: 
*p<.05; **p<.01; ***p<.001 
EDSS=Expanded Disability Status Scale
Discussion 
The aim of this study was to explore whether there are discrepancies in the 
association of depression and anxiety with perceived physical and mental 
health status, and whether these associations differ in younger (<45 years) 
and older (≥45 years) MS patients. Less depression and less anxiety were 
associated with better perceived physical and mental health status in the 
total sample. MS patients without depressed mood and anxiety reported 
signiﬁ   cantly better perceived physical health status than those with 
depression and anxiety when controlled for age, gender, marital status 
and EDSS. Similarly, less depressed and less anxious MS patients assessed 
perceived mental health status as signiﬁ  cantly better when controlled for 
age, gender, marital status and EDSS. Our results regarding perceived 
health status as a dependent variable are in line with previous ﬁ  ndings 
(4, 29-32).105
The described model, which includes depression and anxiety, 
explained the lower variance in the difference in perceived physical health 
status (46.6%) compared with perceived mental health status (60.8%) 
in the total sample. While EDSS was the strongest variable explaining 
perceived physical health status, depression and anxiety appeared to be 
the main variables explaining most of the variance in perceived mental 
health status. Janssens et al (33) showed that the EDSS explained much, 
but not all, of the variance in the physical scale of SF-36, suggesting that 
other additive determinants were involved. An important difference 
between the instruments is that the EDSS aims to assess objective clinical 
status, whereas the SF-36 is a subjective evaluation of physical functioning 
as perceived by the patient (33). 
A low score in depression was associated with better perceived 
physical health status, while a low score in anxiety appeared to be 
signiﬁ  cantly related to better perceived physical health status in younger 
MS patients, but without signiﬁ  cant association in the older age group. 
These ﬁ   ndings provide some support for the results of more recent 
studies, which have suggested that more symptoms of depression and 
anxiety were signiﬁ  cantly associated with worse perceived physical and 
mental health status presented by the SF-36 health summary scales and 
with poorer quality of life in MS patients (17, 30, 33). 
A low score in depression was associated with better perceived 
mental health status in both age groups, with a higher explained prevalence 
of depression in younger MS patients. This ﬁ  nding is comparable to the 
results of some studies in which younger adults reported higher levels of 
depressive symptoms than older adults with MS (34, 35). Depression can 
result from individual reactions to MS-related disability, its symptoms and 
from the disease process itself (14). A low score in anxiety was signiﬁ  cantly 
related to perceived mental health status only in the younger age group. 
The relationship between anxiety and mental health in younger patients 
was studied in a survey of recently diagnosed MS patients whose mean 
age was 37.5±9.5 years. More symptoms of anxiety were associated with 
poorer physical and mental health in this sample (33). 
The existence of unique features in the national health care system 
in the past may lead to a certain limitation of this study. In particular, 
the inaccessibility to DMD for MS patients over age 45 may affect the 
differences when evaluating symptoms of depression and anxiety in 
comparison to patients from other countries in this age cohort. Also, the 
MS patients participating in this study were signiﬁ  cantly younger than 
the non-respondents. We may assume, then, that the non-respondents 
were largely members of the older MS group and with the longest disease 
duration, and that they were possibly the most affected group, a fact that 
might have prevented them from participating in the study. The results 
therefore cannot be extended and generalized to the whole MS population, 106 CHAPTER  6
as a larger proportion of the oldest group of MS patients compared with 
the younger group was missing from this study. In addition, the outcomes 
of this cross-sectional study cannot be causally determined. The current 
survey can only imply causal pathways, not prove them. Longitudinal 
data are needed to further unravel the complex interplay between 
psychological well-being and changes in perceived health status during 
and after DMD treatment in Slovak MS patients. 
Summary and implications
In a summary of the study ﬁ  ndings, depression showed its importance 
for evaluating the perceived health status in all MS patients. Therefore 
depression should be carefully screened for in all MS patients, regardless 
of sociodemographic factors and clinical variables. Among the most 
used therapeutic agents,  -interferon (a DMD) is being widely adopted 
in relapsing-remitting MS (28). In our sample, patients below the age of 
45 years had been treated with  -interferon 1a or 1b. It was recognized 
that among the potential drug-related side effects, there was a possible 
association with an increased risk of depression, a fact which has been 
debated (36). If depression occurs in MS patients, it is hard to conclude 
that the reason is as a side effect of DMD or no accessibility to using 
DMD or any other reason. As DMD moderately reduces the number and 
severity of attacks, the number of new lesions on magnetic resonance 
imaging and progression (37), it may be that older MS patients who had 
no access to DMD feel the impossibility of coping with the disease as their 
younger colleague patients are able to, which might lead to a depressed 
mood. Symptoms of anxiety could be connected with perceived physical 
and mental health in younger MS patients, despite their use of DMD. 
This could be explained by distress caused by possibly worsening 
functional disability at a younger age, which was signiﬁ  cantly associated 
with impairment, and its consequences on education, employment and 
leisure-time physical activity, and with the restricted social network. With 
regard to older MS patients, they could have built up during treatment 
with DMD useful coping strategies during the years of disease and 
thus are able to cope with anxiety when older. Determining the factors 
that could have an impact on an MS patient’s perceived health status 
might help with decision-making during the planning of interventions, 
treatments and services aimed at enhancing health status or quality of 
life (30).
The clinical importance of this study is that MS patients possessing 
higher levels of depression and anxiety have a greater likelihood of 
perceiving health status more negatively than those who are less depressed 
and less anxious. According to the result of the study, health care providers 
would expect that MS patients suffering from depression and anxiety may 107
evaluate their health as worsened. It may be therefore important to assess 
the symptoms of depression and anxiety of MS patients and to treat them 
in order to contribute to a patient’s perceived health status.
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Chapter 7
General discussion and implications for 
future research and practice
In the ﬁ  rst part of this chapter general considerations regarding perceived 
health status and its association to the main variables of the study will be 
discussed. Later, the strengths and some limitations of the study will be 
reviewed. The chapter will end with some suggestions about directions 
for future research on perceived health status in MS patients and with a 
discussion about the implications of the ﬁ  ndings for clinical practice. 
7.1  Discussion of the main findings 
Perceived health status focuses on two areas: physical health status and 
mental health status. In medical patients, including MS patients, the 
physical and mental dimensions of perceived health status are related to 
one another. Many MS patients report a fear of sudden relapses and anxiety 
about disease progression (4). Consequently, they must resist the intrusion 
of negative thoughts that result in a bad mood or the stress that comes 
from the progressive decline in their physical health status. Regarding 
the aims of this work, Chapter 1 contains the theoretical model used in 
the study. We focused on the outcomes of the physical and mental health 
summary scales with the disease process and the functional disability 
associated with physical health status, as well as the psychosocial factors 
related to mental health status. 
Regarding physical health status, the studies reviewed here provided 
support for the negative association of disease duration and a higher score 
in functional disability with the physical health dimensions of the SF-36 
(1, 2). Patti et al (2) actually reported a signiﬁ  cant association between 
all SF-36 health dimensions and disease duration. Similarly, Nortvedt et 
al (5), in a study of 194 MS patients, revealed signiﬁ  cantly lower scores 
in all health dimensions of perceived health status and higher scores in 
functional disability (5). 
The ﬁ  rst item of the SF-36 appeared, in a statistical sense, as a strong 
predictor of employment status in MS patients. In terms of premature 
retirement, non-employment status mainly affects ﬁ  nancial  security 
and leads to a reduced social network and a worsened perceived health 
status. Despite these results, experience shows that society and employers 
assess the efforts of MS patients to work as marginal, and a patient’s 112 CHAPTER  7
opportunities for being employed full-time or part-time are genuinely 
limited. In line with this statement, only about one-third (35.9%) of all 
patients surveyed were employed full-time or part-time, although the 
majority of MS patients had the relapsing-remitting clinical course. 
The next step focused on psychological well-being and perceived 
health status in MS patients. Our results show that less depressed and 
less anxious MS patients assessed their perceived physical and mental 
health status as signiﬁ  cantly better, and that results regarding perceived 
health status as an important dependent variable related to depression 
and anxiety are in line with previous ﬁ  ndings (5-7). 
Social support is considered primarily as a psychosocial construct 
and to a lesser extent, a physical construct. In line with this statement, our 
outcomes did not reveal a strong relationship between social support and 
physical health status. But some studies have consistently shown that social 
support may be a major factor in adaptation to physical illness, and that 
positive social interaction is associated with better physical functioning 
(8, 9). In spite of this fact, social support provided by family and friends 
was positively associated with all of the individual dimensions of mental 
health status in MS patients. Thus, the results of this study are in line with 
the ﬁ  nding that more social support contributes to better mental health (8, 
9). Many authors have shown that social support functions as a protective 
factor against mental health problems (10-12). 
Another psychosocial factor studied was mastery. We concluded 
that higher mastery was associated with better mental health status in 
MS patients. The fact that worse functional disability, higher mastery and 
worse perceived health status are more frequently present in the older 
age group (≥45 years) than in the younger one (<45 years) might suggest 
that the progress of MS should be taken into account. Other authors have 
also found that individuals with greater mastery are more likely to use 
preventive care, have good health behaviours, seek treatment early and 
use health services properly (13-15). 
At the end of the discussion of our main ﬁ  ndings, we would like to 
come back to our earlier statement regarding the fear of sudden relapses 
and disease progression that deeply affects MS patients. The described 
variables, including low functional disability, short disease duration, the 
ability to work and social support provided by signiﬁ  cant others, could 
be factors mainly associated with perceived physical health status in 
MS patients. Secondly, the studied psychosocial factors, including social 
support provided by family and friends, higher mastery and the absence 
of depression and anxiety, could be important determinants of mental 
health status in MS patients. Our study showed that the physical and 
mental health dimensions of perceived health status can only be divided 
for analytical reasons; in reality they operate in patients as a whole. 113
7.2  Study strengths and limitations
Strengths 
With regard to the functional disability of MS patients, not only subjective 
data on physical health status was collected. EDSS, a measure of functional 
disability, was used as an objective health indicator focusing on the level of 
disease severity and was assessed by a neurologist. EDSS was signiﬁ  cantly 
correlated in the total sample of MS patients with the dimensions of the 
physical health summary scale of the SF-36. This scale therefore could be 
recognized as an appropriate measure of perceived physical health status. 
Neurologists, nurses, psychologists and psychiatrists might use it as a 
quick tool for measuring perceived physical health in MS patients.
Since published studies were lacking on the effect of perceived social 
support on the health status of MS patients, our study tried speciﬁ  cally 
to shed more light on this topic. In doing so it revealed that the health 
dimensions of the SF-36 might be associated with a different type of social 
support and could contribute to better perceived health determinants. 
Similarly, little research has thus far been conducted on MS patients 
regarding the associations between mastery, functional disability and 
perceived health status. 
Limitations 
Each of the studies described in this thesis contain a section in which 
the strengths and limitations of the study have already been discussed, 
therefore these factors will only be mentioned here very brieﬂ  y. The 
studies are cross-sectional, so causal relationships cannot be concluded 
from the ﬁ  ndings. The signiﬁ  cantly older age of the non-respondents 
suggests more disease severity among this group, which affects the 
ability to generalize from our study outcomes. A further limitation of our 
outcomes could be the exclusive access of patients under the age of 45 to 
disease-modifying agents. 
However, there are additional issues that should be mentioned. 
Firstly, the study was carried out in a population of MS patients, but not 
in a healthy or general population. It is well known from many previous 
studies on quality of life that MS patients report their health status worse 
than the general population (5, 16-18). Secondly, we agree with the authors 
of Perceived Social Support scale that clariﬁ  cation is needed regarding 
who actually belongs to the signiﬁ  cant others subscale (19).
A number of disease-modifying drugs (DMD) have been developed 
over the past 20 years. Although these drugs have been introduced in 
Central and Eastern Europe, their high cost means many patients do not 
have access to them. The unavailability of DMD for patients over the age 114 CHAPTER  7
of 45 in Slovakia might lead to a certain limitation of this study. There 
is no doubt that a signiﬁ  cant treatment gap exists in approaches to MS 
between countries. DMD are also costly, requiring   15.000 to   26.300 per 
annum per patient, and are beyond the reach of many patients (20). On 
1 July 2008, the Slovak Ministry of Health cancelled the age restriction on 
the use of DMD. As a result, every MS patient for whom DMD might be 
helpful now has, according to a neurologist’s decision, the opportunity 
to use this medicine and have the cost covered by their health insurance 
provider.
7.3  Implications of the findings 
Recommendations for future research
As with many neurological diseases, MS is difﬁ  cult to study. Even after 
several decades of intensive research activity, it remains a condition with 
no known pathogen, and there is no consensus on its origin or accepted 
determinants of its severity. Below are some suggestions for future 
research based on the ﬁ  ndings of this thesis. 
Some neuropsychological studies suggest that 40-65% of MS 
patients show some cognitive dysfunction, prominently involving 
memory, sustained attention and information processing speed. Cognitive 
functioning has a dramatic impact on a patient’s well-being, inﬂ  uencing 
role fulﬁ  llment in both work and social life (21-23). A patient’s cognitive 
dysfunction could be assessed by speciﬁ  c neuropsychological measures 
(23). Thus, researchers might want to study how cognitive functioning is 
associated with perceived health status in MS patients. We might expect 
some limitations in the dimensions of the mental health summary scale 
depending on its linkage with cognitive functioning. 
Physical fatigue and mental fatigue are frequently reported negative 
factors in people with MS. The symptoms of depression and fatigue are very 
similar, however, and it may be difﬁ  cult to differentiate them; sometimes a 
trial of antidepressants may be necessary (20). As the subjective experience 
of fatigue is one of the most common symptoms in MS patients and is 
certainly associated with reduced health, the association in which fatigue 
impacts perceived health status has not yet been clearly deﬁ  ned (24-26). 
We can assume that since the score in functional disability is inﬂ  uenced 
by limb and gait dysfunction, fatigue might very well be linked with the 
physical domain of perceived health status. 
It would be interesting to ascertain whether positive experiences 
directly enhance the perceived physical and mental health status of MS 
patients. How MS patients cope with stressors may be affected not only 
by their mastery over life circumstances but also by the social support 115
provided. People with a diagnosed disorder might differ from those who 
score high on psychological symptom scales in social characteristics and 
in life event experiences. Additionally, hardiness, a sense of coherence, 
and Type A characteristics such as impatience and hostility have been 
studied as factors relevant for coping with disease. Pearlin and Schooler 
(27) distinguished between perception-focused coping strategies and 
emotion-management strategies. Furthermore, behavioral self-efﬁ  cacy 
has been related to health-promoting behaviour and to positive physical 
health outcomes (27-30). Focusing more on stress and the coping strategies 
used by MS patients could be a very important part of future research.
The extended model, with elements of cognitive functioning, fatigue, 
stress and coping strategies, might serve as a framework for future research 
on MS patients (Figure 1). This model with perceived health status might 
also be studied in a comparison of MS patients and the general population 
within a cross-sectional theoretical framework.
Figure 1 Framework for future research 
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MS patients are usually diagnosed in the ﬁ  rst part of their life 
trajectories, when career and starting a family are major issues. With a 
renewal of the theoretical framework, future research could focus on if and 
how the life plans of younger MS patients might change and be affected 
by such a distressing factor. A longitudinal study would be appropriate 
for revealing these changes in MS patients over time. Furthermore, 
longitudinal data would be needed to further unravel the complex 
interplay between psychological well-being and changes in perceived 
health status in MS patients during and after treatment with the disease-
modifying agents.116 CHAPTER  7
Clinical implications
MS patients achieved an average score in perceived physical and mental 
health status; thus, many MS patients experienced good health status. But 
a minority of them, mainly older people with MS, does not experience a 
satisfactory physical health status. 
Even though drug treatment options are relatively limited, signiﬁ  cant 
improvements in the well-being of people with MS might be supported 
by more intensive rehabilitation approaches. For patients with relatively 
moderate disability, both aerobic and non-aerobic exercise, for example, 
has been found to be very useful. There is a need for more studies 
evaluating the rehabilitation needs of MS patients experiencing with 
more severe disability. Similarly, neuro-rehabilitation aiming to improve 
independence leads individuals with MS to adapt their lifestyle.
People with MS might also beneﬁ  t from psychosocial intervention. 
Cognitive-behavioural therapy focuses on unrealistic beliefs and replaces 
them with realistic beliefs. Such therapy might help patients adapt to life 
circumstances that are beyond their control. A good family background 
and a network of friends have been shown to be important for mental 
health status. If social support is lacking, intervention programmes might 
therefore be of help. Additive psychosocial treatment, including support 
groups and family therapy, should focus not only on patients, but also on 
wider family interactions. 
There is still a need for a multidisciplinary MS service and 
multimodal approach to symptom management. Caring for MS patients 
used to increase in line with worsened functional disability. Uncertainty 
over the origin or progression of MS indicates that prevention is currently 
not a realistic option. An approach in managing treatment, centered on MS 
patients should include medication appropriate to the level of functional 
disability, followed by management of additive symptoms, mainly 
including fatigue, spasticity, pain, anxiety, depression, bladder and bowel 
dysfunction, imbalance, visual loss, cognitive impairment, etc. (20). 
National MS societies, MS patients, their families, governments, 
health, social and care providers, employers, researchers and others might 
try to use services and improvements in their programmes which include 
independence, medical care, long-term care and social care, health 
promotion, support for family members, transportation, employment and 
volunteer activities, disability beneﬁ  ts, cash assistance and education for 
MS patients. MS patients should be educated about the possibilities of MS 
development and regarding how to adopt satisfactory coping strategies. 
Such a health care network should consist not only of neurologists, but also 
nurses, physiotherapists, occupational therapists, speech and language 
therapists, clinical psychologists, social workers and psychiatrists who 
should stress this goal (20). 117
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Summary 
Most people live with an ‘illusion of invulnerability’. After diagnosis of a 
chronic disease like MS, this illusion is broken, and this loss of perspective 
may be devastating, particularly in early or middle adulthood. Disease 
onset of MS before the age of 10 or after the age of 50 is considered rare. A 
number of large epidemiological studies, but not all, on the natural history 
of MS have found that late age of onset, male gender and a short interval 
between onset and ﬁ  rst relapse are associated with a poor prognosis. The 
progression of MS has been related to worsened functional disability as 
expressed in MS patients by Kurtzke’s EDSS scale. As the measures of 
perceived health status include physical health dimensions, functional 
disability and health status outcomes reported by MS patients may be 
linked very closely.
Chapter 1 of this thesis elaborates on the background of MS, with 
its clinical criteria, treatment and prognosis. This is followed by a general 
model of disability and by health status as applied in MS. Terms like 
disease, impairment, disability, handicap and quality of life established in the 
International Classiﬁ  cation of Impairments, Disabilities and Handicaps 
(ICIDH) might be considered in the context of MS outcomes. At the 
end of this chapter, the aims of the study and research questions are 
formulated, focusing on a review of the literature on disease duration, 
functional disability, psychological well-being and perceived health status 
in MS (Chapter 2); self-rated health and its association to employment 
status in MS (Chapter 3); social support provided by family, friends and 
signiﬁ  cant others and its positive associations with perceived physical and 
mental health status (Chapter 4); the associations of mastery, functional 
disability and perceived health status in MS (Chapter 5); and ﬁ  nally, the 
relationships between depression, anxiety and perceived health status in 
the whole sample as well as separately in the younger and older groups 
of MS patients (Chapter 6). 
Chapter 2 reviews recent studies concerning perceived health 
status in MS patients as measured by the Short Form-36 Health Survey 
(SF-36). The study focuses on the use of the physical and mental health 
dimensions of the SF-36 that are linked to clinical data (disease duration 
and functional disability) and psychological well-being (depression). A 
computer-aided search in Medline and PsycINFO resulted in 504 articles 
in English published from 1996 to August 2006. Just 8 articles consisted 
of empirical MS studies in which perceived health status was evaluated 
using the SF-36. MS patients with low functional disability, shorter 
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patients with high functional disability, long disease duration and major 
depression in the SF-36 health summary scales. 
Chapter 3 focuses on the association between the self-rated health 
of MS patients and employment status. Self-rated health was chosen as 
the ﬁ  rst item of the SF-36 for a short subjective screening of health status. 
In addition to self-rated health, other important variables, including 
functional disability, disease duration, depression and anxiety, were 
examined as independent variables, while employment status was 
treated as a dependent variable. Results showed that MS patients who 
reported good self-rated health were more likely to be employed, less 
disabled and less anxious. Age, gender, disease duration and depression 
showed no statistically signiﬁ  cant association with employment or non-
employment in MS patients. It should be mentioned that only about 
half of the surveyed MS patients were employed full-time or part-time, 
although 68% of all patients belonged to the relapsing-remitting clinical 
course. This means that the possibilities of MS patients of being employed 
are really limited. 
Perceived social support has shown its usefulness in the chronically 
ill as a psychosocial factor and coping strategy. People who look to others 
to support them report feeling strengthened and encouraged. Having 
someone who openly and willingly talks about MS and its challenges 
provides a patient with a positive coping style. The ﬁ  rst aim of the study, 
described in Chapter 4, was to assess the association between social 
support provided by family, friends and signiﬁ  cant others and perceived 
physical and mental health status in MS patients. The second aim 
focused on evaluating the social support provided by family, friends and 
signiﬁ  cant others in association with the separate dimensions of perceived 
physical and mental health status. Social support from signiﬁ  cant others 
was positively associated with the general health dimension of perceived 
physical health status, while social support from family and friends was 
positively associated with all four dimensions of perceived mental health 
status. The results show the importance of supporting social ties and 
relationships between MS patients and others. 
Along with social support, mastery, as in having a sense of control, 
was identiﬁ  ed as an important variable in a patient’s psychological well-
being. Chapter 5 deals with the associations between mastery, functional 
disability and perceived health status in MS patients. With regard to 
age and the use of disease-modifying drugs, differences were expected 
in mastery, functional disability and perceived health status between 
younger and older age groups of MS patients (<45 and ≥45 years of age). 
Patients with low functional disability reported better physical health 
status in both age groups and better mental health status in the younger 
age group. Mastery was positively associated with perceived health status 
in the older age group. The ﬁ  ndings conﬁ  rmed that mastery might be 123
helpful for older MS patients, while functional disability appeared to be 
the most important variable for younger age group. 
Depression and anxiety were found to be signiﬁ  cant  variables 
associated with perceived health status, as described in Chapter 6. 
Comparable to Chapter 5, the study sample consisted of 223 MS patients 
who were divided into two age groups (<45 and ≥45 years of age). The role 
of depression was present with regard to perceived health status, mainly 
to perceived physical health status in the older group and to perceived 
mental health status in the younger one. The role of anxiety was more 
important in younger MS patients than among older patients with regard 
to their perceived health status. 
Finally, in Chapter 7 the main ﬁ  ndings of the studies described in 
this thesis are discussed and placed within a broader context. This chapter 
also reﬂ  ects the importance of the model used as the framework for this 
thesis. The chapter ends with a discussion on the clinical implications of 
the work. 
Several recommendations are made about directions for future 
research and practice: to continue this research in a longitudinal study 
in order to compare both cross-sectional data and longitudinal data; to 
extend the theoretical framework by adding new variables; to support 
better perceived health status in MS patients through rehabilitation 
and neuro-rehabilitation approaches; to follow up with psychosocial 
interventions, including cognitive-behavioural therapy, social support, 
group therapy etc.; to provide a multidisciplinary approach in symptom 
treatment that would be directed toward patients with MS. 
Unexpected worsened disability may affect patients with MS fearing 
prognostic uncertainty, and they should thus become well informed about 
their illness. Collaboration is essential in the plan of care between patient, 
family and health care providers. Treating physicians should continually 
assess the need for psychological support for patients and their families, 
since depression is common and the rate of suicide is relatively high in this 
population of patients. Therefore, a multidisciplinary approach is needed 
for several of the complications of MS that may involve specialists in 
physical medicine and rehabilitation. Recent progress in treatment showed 
that advanced magnetic resonance imaging (MRI) and spectroscopy may 
allow clinicians to follow the pathological progression of the disease and 
to monitor the response to treatment. In parallel with the development 
of new diagnostics methods and clinical treatments, researchers have 
recently begun to recognize the association between disease progress and 
the psychosocial factors of MS. 124 SUMMARY125
Samenvatting
Veel mensen leven met een soort ‘illusie van onkwetsbaarheid’. Na de 
diagnose van een chronische ziekte zoals MS gaat deze illusie teloor, en 
het verlies van perspectief kan aanzienlijk zijn, speciaal in de periode van 
jong of middenvolwassenheid. Het begin van MS voor het tiende of na het 
vijftigste levensjaar is zeldzaam. Uit een aantal epidemiologische studies 
met betrekking tot het natuurlijk verloop van MS, maar niet uit alle, blijkt 
dat het late optreden ervan, het mannelijke geslacht en een kort interval 
tussen begin van de ziekte en de eerste terugval gerelateerd is met een 
slechte prognose. De progressie van MS wordt gewoonlijk gekoppeld 
aan functionele beperkingen tengevolge van de ziekte, uitgedrukt door 
Kurtzke’s Expanded Disability Status Scale (EDSS) schaal. Naast deze 
door de arts vastgestelde gezondheidstoestand is er de door de patient 
‘ervaren gezondheidstoestand’; omdat deze ook betrekking heeft op de 
lichamelijke gezondheidsdimensies, zijn functionele beperkingen en de 
uitkomsten van de gezondheidstoestand nauw aan elkaar verwant.
In Hoofdstuk 1 van dit proefschrift wordt ingegaan op de achtergrond 
van MS en de klinische criteria, de behandeling en de prognose ervan. In 
een erop volgend algemeen model met betrekking tot beperkingen wordt 
dat toegepast op MS. Termen zoals ziekte, stoornissen, beperkingen, handicap 
en kwaliteit van leven, genoemd in de International Classiﬁ  cation of 
Impairments, Disabilities and Handicaps (ICIDH) kunnen ook in de context 
van MS uitkomsten worden gebruikt. Aan het eind van dit hoofdstuk 
worden doelen van het onderzoek en de onderzoeksvragen genoemd. Ze 
zijn gericht op een review van de literatuur over ziekteduur, functionele 
beperkingen, psychisch welbevinden en ervaren gezondheidstoestand bij 
MS (Hoofdstuk 2); op ervaren gezondheidstoestand en de relatie ervan met 
het hebben van werk bij MS (Hoofdstuk 3); op sociale steun door familie, 
vrienden, en belangrijke anderen en de relatie ervan met ervaren fysieke en 
psychische gezondheidstoestand (Hoofdstuk 4); op de verbanden tussen 
mastery, functionele beperkingen, en ervaren gezondheidstoestand bij MS 
(Hoofdstuk 5); en tenslotte op de verbanden tussen depressie, angst, en 
ervaren gezondheidstoestand in de hele steekproef, en afzonderlijk in de 
oudere en jongere groep MS patiënten (Hoofdstuk 6).
In Hoofdstuk 2 wordt de literatuur met betrekking tot ervaren 
gezondheidstoestand gemeten met de Short Form-36 Health Survey (SF-
36) gereviewed. Het hoofdstuk is gericht op het gebruik van de fysieke 
en psychische dimensies van de SF-36 die gerelateerd zijn aan klinische 
data (ziekteduur en functionele beperkingen) en psychisch welbevinden 
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en PsycINFO resulteerde in 504 Engelstalige artikelen, gepubliceerd van 
1996 tot augustus 2006. In slechts 8 artikelen werden empirisch onderzoek 
onder MS patiënten gerapporteerd waarbij ervaren gezondheidstoestand 
was gemeten met behulp van de SF-36. MS patiënten met een gering aantal 
functionele beperkingen, een korte ziekteduur, en weinig depressieve 
klachten scoorden signiﬁ  cant beter op de fysieke en psychische dimensies 
van de SF-36 dan patiënten met een groot aantal functionele beperkingen, 
een lange ziekteduur, en veel depressieve klachten.
In Hoofdstuk 3 wordt het verband tussen ervaren gezondheid-
stoestand bij MS patiënten en het hebben van werk beschreven. De ervaren 
gezondheidstoestand werd gemeten met de eerste vraag van de SF-36 
om een korte subjectieve indruk van de gezondheidstoestand te krijgen. 
Naast de ervaren gezondheidstoestand werden de variabelen functionele 
beperkingen, ziekteduur, depressie en angst gebruikt als onafhankelijke 
variabelen, terwijl het hebben van werk als afhankelijke variabele werd 
behandeld. MS patiënten met een goede ervaren gezondheidstoestand en 
die minder beperkt en minder angstig waren bleken meer kans op van 
werk te hebben. Er bestond geen statistisch signiﬁ  cant verband tussen 
leeftijd, geslacht, ziekteduur en depressie en het hebben van werk van MS 
patiënten. Ongeveer de helft van de onderzochte MS patiënten hadden 
full time of parttime werk hoewel 68% van alle patiënten tot het ‘relapsing-
remitting’ type behoorde. Kansen voor MS patiënten om werk te krijgen 
zijn zeer beperkt.
Van ervaren sociale steun als een van de psychosociale factoren en 
coping strategieën is bekend dat het nuttig is bij chronisch zieken. Mensen 
die op anderen gericht zijn en hun steunen, geven aan zich daardoor 
gesterkt en bemoedigd te voelen. Er is sprake van een positieve coping 
stijl als de patient iemand heeft met wie hij openlijk en vrijwillig kan 
spreken over MS en de problemen die zich erbij voordoen. Het eerste 
doel van het onderzoek dat is beschreven in Hoofdstuk 4 was het nagaan 
van het verband tussen sociale steun geboden door familie, vrienden, en 
belangrijke anderen en ervaren fysieke en psychische gezondheidstoestand 
in MS patiënten. Het tweede doel was gericht op het onderzoeken van 
het verband tussen sociale steun geboden door familie, vrienden, en 
belangrijke anderen en de verschillende dimensies van ervaren fysieke en 
psychische gezondheidstoestand. Sociale steun afkomstig van belangrijke 
anderen was positief geassocieerd met de algemene gezondheidsdimensie 
van de ervaren fysieke gezondheidstoestand, terwijl sociale steun van 
familie en vrienden positief geassocieerd was met alle vier dimensies van 
ervaren psychische gezondheidstoestand. De resultaten laten het belang 
van steunende sociale verbanden zien tussen MS patiënten en anderen.
Naast sociale steun bleek mastery - het gevoel controle te hebben - een 
belangrijke variabele voor het psychisch welbevinden van de patiënt. In 
Hoofdstuk 5 wordt ingegaan op de verbanden tussen mastery, functionele 127
beperkingen en ervaren gezondheidstoestand bij MS patiënten. Vanwege 
de leeftijd en het toegestane gebruik van disease modifying drugs werden 
verschillen verwacht tussen mastery, functionele beperkingen en ervaren 
gezondheidstoestand tussen jongere en oudere MS patiënten (<45 en 
≥45 jaar). Patienten met geringe functionele beperkingen gaven in beide 
leeftijdsgroepen aan een betere ervaren fysieke gezondheidstoestand te 
hebben, en in de jongere leeftijdsgroep ook een betere ervaren psychische 
gezondheidstoestand. Mastery bleek geassocieerd met een betere ervaren 
gezondheidstoestand de oudere leeftijdsgroep. De resultaten lijken te 
suggereren dat mastery van nut is voor oudere MS patiënten, terwijl 
functionele beperkingen de belangrijkste variabele is voor de jongere 
leeftijdsgroep.
Uit Hoofdstuk 6 blijkt dat tussen depressie en angst enerzijds 
en ervaren gezondheidstoestand anderzijds een signiﬁ  cant  negatief 
verband bestaat. Net als in Hoofdstuk 5 werd de onderzoeksgroep van 
223 MS patiënten verdeeld in twee leeftijdsgroepen (<45 en ≥45 jaar). Met 
betrekking tot ervaren gezondheidstoestand was de rol van depressie 
aanwezig, in het bijzonder bij ervaren fysieke gezondheidstoestand in 
de oudere leeftijdsgroep en ervaren psychische gezondheidstoestand 
in de jongere leeftijdsgroep. De rol van angst bleek meer van belang bij 
jongere dan bij oudere MS patiënten met betrekking tot hun ervaren 
gezondheidstoestand.
Tenslotte worden in Hoofdstuk 7 de belangrijkste bevindingen van 
dit proefschrift beschreven en in een bredere context bediscussieerd. Ook 
wordt ingegaan op het belang van het model dat gebruikt werd als kader 
voor dit onderzoek. Het hoofdstuk eindigt met een discussie over een 
aantal klinische aanbevelingen.
Verschillende aanbevelingen worden gedaan inzake toekomstig 
onderzoek en de praktijk. Dit onderzoek behoeft een longitudinale 
voortzetting om cross-sectionele en longitudinale data te kunnen 
vergelijken; voorts zouden nieuwe variabelen aan de opzet moeten worden 
toegevoegd. MS patiënten zouden een betere ervaren gezondheidstoestand 
kunnen bereiken door meer gerichte revalidatie en neuro-revalidatie; 
voorts zouden ze psychosociale interventie kunnen volgen met daarin 
cognitieve gedragsbehandeling, sociale steun, groepstherapie etc; en 
tenslotte zou een multidisciplinaire aanpak bij de behandeling van 
symptomen aangeboden moeten worden aan MS patiënten.
Onverwachte verslechtering kan MS patiënten confronteren met 
onzekerheid over de prognose en ontwikkeling van hun beperkingen; 
om die reden moeten ze goed geïnformeerd zijn over wat hun te wachten 
staat. Samenwerking is essentieel in het behandelplan tussen patiënt, 
diens naaste familie en de zorgverleners. Behandelende artsen dienen ook 
continu de behoefte aan psychische steun bij patiënten en hun families na te 
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in deze patiëntencategorie. Daarnaast is een multidisciplinaire aanpak 
nodig vanwege de complicaties van MS, met inbreng van de deskundigheid 
van fysiotherapeuten en revalidatie-artsen in het begeleidingsproces. 
Een recente ontwikkeling in de behandeling is de advanced magnetic 
resonance imaging (MRI) en spectroscopie die clinici in staat stelt het 
pathologische substraat van het voortschrijden van de ziekte zichtbaar te 
maken alsmede het effect van de behandeling te volgen. De ontwikkeling 
van nieuwe diagnostische middelen en klinische behandelwijzen laat 
onverlet het belang van onderzoek naar het voortschrijden van de ziekte 
en de psychosociale factoren bij MS.129
Zhrnutie
Mnohí ľudia sú presvedčení, že im sa nemôže stať, že ochorejú. Po 
diagnostikovaní chronického ochorenia, akým je skleróza multiplex (SM), 
sa táto ilúzia rúca. Strata ďalšej perspektívy, najmä v období mladšieho 
a stredného dospelého veku, môže byť zničujúca. Nástup SM pred desia-
tym rokom alebo po päťdesiatom roku života sa považuje za ojedinelý. 
Veľký počet rozsiahlych epidemiologických štúdií o pôvode SM uvádza, 
že neskorší nástup ochorenia, mužské pohlavie, krátky interval medzi ná-
stupom a prvým relapsom sa spája s horšou prognózou ochorenia. Prog-
res SM sa pripisuje zhoršenému funkčnému stavu, ktorý sa u pacientov 
so SM vyjadruje pomocou Kurtzkeho škály EDSS. Keďže metódy seba-
posudzovania zdravotného stavu zahŕňajú dimenzie fyzického zdravia, 
výsledky sebaposudzovaného zdravia sa môžu úzko prelínať s funkčným 
stavom ako odrazom zhoršenie fyzického zdravia. 
V kapitole 1 je opísané pozadie vzniku SM, vrátane klinických krité-
rií, liečebných postupov a prognózy ochorenia. Sleduje všeobecne uplat-
ňovaný model funkčnej neschopnosti a zdravotného stavu, ktorý možno 
aplikovať u SM. Terminológia v tejto kapitole zahŕňa pojmy ako choroba, 
postihnutie, neschopnosť, hendikep a kvalita života, čo sú pojmy zavede-
né v medzinárodnej klasiﬁ  kácii International Classiﬁ  cation of Impairments, 
Disabilities and Handicaps (ICIDH). Tieto pojmy možno uplatniť v kontexte 
výskumu SM. V závere tejto kapitoly sa uvádzajú ciele štúdie a jej vý-
skumné otázky, prehľad doteraz publikovanej literatúry o dĺžke ocho-
renia, funkčnom stave, psychickej pohode a sebaposudzovanom zdraví 
(Kapitola 2); sebaposudzované zdravie ako jedna položka a jeho vzťah 
k zamestnanosti (Kapitola 3); sociálna opora, ktorú poskytuje rodina, 
priatelia a iní významní ľudia a jej pozitívny vzťah k sebpoasudzovanému 
fyzickému a duševnému zdraviu (Kapitola 4); súvislosti medzi mastery, 
funkčným stavom a sebaposudzovaným zdravím (Kapitola 5); a nakoniec, 
vzťahy medzi depresiou, anxietou a sebaposudzovaným zdravím v celom 
skúmanom súbore SM pacientov, ako aj osobitne v dvoch skupinách pa-
cientov rozdelených podľa veku (Kapitola 6). 
Kapitola 2 zobrazuje prehľad posledných článkov, ktoré sú oriento-
vané na sebaposudzované zdravie merané dotazníkovou metódou Short 
Form-36 Health Survey (SF-36). Tento prehľad literarúry zdôrazňuje fyzic-
ké a mentálne dimenzie dotazníka SF-36 v súvislosti s využitím klinických 
údajov (dĺžka ochorenia, funkčný stav) a psychickej pohody (depresia). 
Elektronické vyhľadávanie v databázach Medline a PsycINFO vyústilo 
do výsledkov v podobe 504 článkov, ktoré boli publikované v anglickom 
jazyku v období januára 1996 až augusta 2006. Len 8 nájdených článkov 130 ZHRNUTIE
obsahovalo empirické štúdie o SM, v ktorých sa sebaposudzované zdravie 
hodnotilo prostredníctvom metódy SF-36. Tento prehľadový článok uvá-
dza, že SM pacienti s dobrým funkčným stavom, krátkou dĺžkou ocho-
renia a nízkou depresiou skórovali štatisticky lepšie v škálach dotazníka 
SF-36 než pacienti so zhoršeným funkčným stavom, zdĺhavým ochorením 
a zvýšenou depresiou. 
Kapitola 3 sa zaoberá vzťahom medzi sebaposudzovaným zdravím 
a zamestnanosťou pacientov so SM. Sebaposudzované zdravie odzrkad-
ľuje v tejto práci 1. otázka z dotazníka SF-36 ako rýchly a subjektívny opis 
zdravotného stavu pacienta. Okrem sebaposudovaného zdravia hodnotili 
pacienti ďalšie dôležité premenné vrátane funkčného stavu, dĺžky ocho-
renia, depresie a anxiety, ktoré boli v tomto prípade nezávislými premen-
nými. Zamestnanosť hodnotili potom ako závislú premennú. Výsledky 
ukázali, že pacienti so SM, ktorí označili svoje zdravie ako dobré, boli 
menej zneschopnení, menej úzkostní a mali väčšiu šancu zamestnať sa. 
Vek, pohlavie, dĺžka ochorenia a depresia nesúviseli štatisticky významne 
so zamestnanosťou alebo nezamestnanosťou v dôsledku ochorenia. Tre-
ba spomenúť, že v čase snímania údajov v priemere asi polovica skúma-
ných pacienov so SM pracovala na celý alebo čiastočný úväzok, hoci 68% 
všetkých skúmaných pacientov malo diagnostikovanú relaps-remitujúcu 
formu ochorenia. Tento rozpor svedčí o pretrvávajúcich obmedzených 
možnostiach nájsť si prácu s touto diagnózou. 
Sociálna opora ukázala svoju opodstatnenosť pri skúmaní chronic-
kých ochorení ako psychosociálny faktor a copingová stratégia. Ľudia, 
ktorým sú ostatní oporou, hovoria o pocitoch väčšej sily a odvahy. To ve-
die k pozitívnemu štýlu zvládania ochorenia, najmä ak pri pacientovi stojí 
niekto, kto s ním otvorene a ochotne hovorí o problémoch so SM. Prvá 
hypotéza v kapitole 4 sa zamerala na hodnotenie vzťahu medzi sociál-
nou oporou poskytovanou rodinou, priateľmi a inými dôležitými ľuďmi 
a sebaposudzovaným fyzickým a duševným zdravotným stavom. Druhá 
hypotéza sa dotýkala hodnotenia sociálnej opory v súvislosti s jednotlivý-
mi dimenziami sebaposudzovaného zdravotného stavu. Výsledky analýz 
ukázali, že sociálna opora poskytovaná inými dôležitými ľuďmi súvisela 
pozitívne s jednou z ôsmych diemenzií, a to so „všeobecným zdravím“. 
Sociálna opora od rodiny a priateľov pozitívne významne súvisela so 
všetkými štyrmi dimenziami v rámci sebaposudzovaného duševného 
zdravia. Tieto výsledky poukazujú na dôležitosť podporovať sociálne 
putá a vzťahy medzi pacientami so SM a ostatnými ľuďmi. 
Okrem sociálnej opory, za ďalšiu podstatnú premennú pre psychic-
kú pohodu pacientov so SM možno považovať mastery ako zmysel mať 
pod kontrolou udalosti života. Kapitoly 5 skúma vzťahy medzi mastery, 
funkčným stavom a sebaposudzovaným zdravím u pacientov so SM. 
Vzhľadom na vek a užívanie liekov ovplyvňujúcich priebeh choroby sa 
dali očakávať rozdiely medzi mastery, funkčným stavom a sebaposu-131
dzovaným zdravím medzi mladšími a staršími pacientami so SM (<45 
a ≥45 rokov). Pacienti s lepším funkčným stavom udávali lepšie fyzické 
zdravie v oboch vekových skupinách a lepšie duševné zdravie udávali 
mladší pacienti so SM. Mastery pozitívne súviselo so sebaposudzovaným 
zdravím v staršej vekovej skupine pacientov. Tieto zistenia potvrdili, že 
mastery môže byť užitočné u starších pacientov, kým funkčný stav sa zdá 
byť zo skúmaných premenných najdôležitejšou premennou v mladšej ve-
kovej skupine. 
V kapitole 6 sa sledoval vzťah depresie a anxiety v súvislosti so se-
baposudzovaným zdravím u pacientov so SM. Skúmaný súbor pozostával 
z 223 pacientov so SM. Podobne ako v kapitole 5, pacienti boli rozdelení 
do dvoch vekových skupín podľa užívania liekov ovplyvňujúcich prebeh 
ochorenia (<45 a ≥45 rokov). Významnosť depresie sa ukázala vo vzťahu 
k sebaposudzujúcemu fyzickému zdraviu v skupine starších pacientov 
a voči sebaposudzujúcemu duševnému zdraviu v skupine mladších pa-
cientov so SM. Anxieta sa prejavila ako dôležitejší faktor sebaposudzova-
ného zdravia v  mladšej vekovej skupine pacientov so SM. 
Nakoniec, kapitola 7 zahŕňa hlavné zistenia tejto štúdie a rozpraco-
váva ich v širšom kontexte. Tak isto reﬂ  ektuje opodstatnenosť teoretic-
kého modelu, ktorý slúžil ako podklad pre túto prácu a končí diskusiou 
o možnostiach uplatnenia poznatkov v klinickej praxi. 
Táto práca poskytuje niekoľko odporúčaní pre budúci výskum a prax: 
pokračovať v longitudinálnom výskume a porovnať údaje z prierezovej 
štúdie a longitudinálneho výskumu; rozšíriť teoretický rámec výskumu 
o skúmanie ďalších faktorov; podporovať rehabiltačné a neurorehabili-
tačné aktivity pacientov pre zlepšenie sebaposudzovaného zdravotného 
stavu; podieľať sa na psychosociálnych intervenciách napr. kognitívno-be-
hviorálnej terapii, sociálnej opore a skupinovej psychoterapii; zabezpečiť 
multidisciplinárny pístup k liečbe symptómov u pacientov so SM. 
Nečakané zhoršenie funkčného stavu môže spôsobiť pacientom so 
SM obavy z neistej prognózy. Preto by mali byť veľmi dobre informovaní 
o svojom ochorení. Základom v starostlivosti o pacienta je spolupráca me-
dzi ním, rodinou a zdravotníckym personálom. Lekári by mali neustále 
sledovať, či je potrebné poskytnúť pacientovi a jeho rodine psychologickú 
pomoc, keďže depresia býva častá a výskyt samovrážd v tejto skupine pa-
cientov býva relatívne vysoký. Kvôli mnohým komplikáciám v dôsledku 
SM je v medicínskej a fyzioterapeutickej liečbe potrebný multidisciplinár-
ny prístup. Nedávny pokrok v liečbe ukázal, že magnetická rezonancia 
(MRI) a spektroskopia umožňujú lekárom sledovať patologický postup 
ochorenia a  reakcie pacientov na liečbu. Paralelne s vývojom nových 
diagnostických metód a liečby začali vedci viacej chápať súvislosti medzi 
progresom ochorenia a vplyvom psychosociálnych faktorov u pacientov 
so SM.132 ZHRNUTIE133
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